{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:04:20Z","timestamp":1790417060187,"version":"4.1.0"},"reference-count":334,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10787-025-01844-5","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T13:58:15Z","timestamp":1753192695000},"page":"4125-4165","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Phytochemical modulation of mTOR signaling: emerging nanotechnology-driven therapeutics for rheumatoid arthritis management"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8505-7038","authenticated-orcid":false,"given":"Deepa","family":"Mandlik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prapti","family":"Adgaonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Mandlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"issue":"5","key":"1844_CR1","first-page":"755","volume":"82","author":"MM Abbas","year":"2021","unstructured":"Abbas MM et al (2021) Quercetin potentiates the anti-inflammatory and anti-arthritic effects of methotrexate in adjuvant-induced arthritis in rats. Drug Dev Res 82(5):755\u2013764","journal-title":"Drug Dev Res"},{"issue":"1","key":"1844_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.biocel.2008.06.010","volume":"41","author":"BB Aggarwal","year":"2009","unstructured":"Aggarwal BB, Harikumar KB (2009) Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 41(1):40\u201359","journal-title":"Int J Biochem Cell Biol"},{"key":"1844_CR3","first-page":"10175","volume":"15","author":"T Ahmed","year":"2020","unstructured":"Ahmed T, Aljaeid BM (2020) Preparation, characterization, and evaluation of curcumin nanoemulsion for treatment of rheumatoid arthritis. Int J Nanomed 15:10175\u201310194","journal-title":"Int J Nanomed"},{"issue":"8","key":"1844_CR4","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/S0891-5849(02)01004-3","volume":"33","author":"S Ahmed","year":"2002","unstructured":"Ahmed S et al (2002) Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1\u03b2-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. Free Radic Biol Med 33(8):1097\u20131105","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"1844_CR5","first-page":"305","volume":"26","author":"S Ahmed","year":"2015","unstructured":"Ahmed S, Wang N, Lalonde M, Goldberg VM, Haqqi TM (2015) Green tea polyphenol epigallocatechin-3-gallate (EGCG) blocks IL-1\u03b2-induced expression of matrix metalloproteinase-1 and -13 in human chondrocytes via suppression of MAPK and NF-\u03baB pathways. J Nutr Biochem 26(3):305\u2013312","journal-title":"J Nutr Biochem"},{"key":"1844_CR6","volume":"243","author":"S Ahmed","year":"2020","unstructured":"Ahmed S et al (2020) Therapeutic potential of epigallocatechin-3-gallate (EGCG) in autoimmune diseases. Life Sci 243:117287","journal-title":"Life Sci"},{"issue":"9","key":"1844_CR7","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/pharmaceutics13091475","volume":"13","author":"WS Alharbi","year":"2021","unstructured":"Alharbi WS et al (2021) Phytosomes as an emerging nanotechnology platform for the topical delivery of bioactive phytochemicals. Pharmaceutics 13(9):1475","journal-title":"Pharmaceutics"},{"key":"1844_CR8","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s40265-018-0908-4","volume":"78","author":"ZT Al-Salama","year":"2018","unstructured":"Al-Salama ZT, Scott LJ (2018) Baricitinib: a review in rheumatoid arthritis. Drugs 78:761\u2013772","journal-title":"Drugs"},{"issue":"6","key":"1844_CR9","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/RHU.0000000000000571","volume":"23","author":"A Amalraj","year":"2017","unstructured":"Amalraj A et al (2017) Effects of bioavailable curcumin (CurQfen) in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. J Clin Rheumatol 23(6):324\u2013330","journal-title":"J Clin Rheumatol"},{"issue":"6","key":"1844_CR10","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/mp700113r","volume":"4","author":"P Anand","year":"2007","unstructured":"Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4(6):807\u2013818","journal-title":"Mol Pharm"},{"issue":"8","key":"1844_CR11","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.biotechadv.2015.08.001","volume":"33","author":"AG Atanasov","year":"2015","unstructured":"Atanasov AG et al (2015) Discovery and resupply of pharmacologically active plant-derived natural products: a review. Biotechnol Adv 33(8):1582\u20131614","journal-title":"Biotechnol Adv"},{"issue":"1","key":"1844_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1142\/S0192415X16500014","volume":"44","author":"KK Auyeung","year":"2016","unstructured":"Auyeung KK, Han QB, Ko JK (2016) Astragalus membranaceus: a review of its protection against inflammation and gastrointestinal cancers. Am J Chin Med 44(1):1\u201322","journal-title":"Am J Chin Med"},{"key":"1844_CR13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13075-015-0630-5","volume":"17","author":"S Awasthi","year":"2015","unstructured":"Awasthi S et al (2015) mTOR inhibition enhances the anti-inflammatory effects of methotrexate in autoimmune arthritis. Arthritis Res Ther 17:134","journal-title":"Arthritis Res Ther"},{"key":"1844_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-018-1592-1","volume":"20","author":"E Balogh","year":"2018","unstructured":"Balogh E et al (2018) Oxidative stress impairs energy metabolism in primary cells and synovial tissue of patients with rheumatoid arthritis. Arthritis Res Ther 20:1\u20135","journal-title":"Arthritis Res Ther"},{"issue":"1\u20132","key":"1844_CR15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ejphar.2011.06.006","volume":"668","author":"D Banji","year":"2011","unstructured":"Banji D et al (2011) Synergistic activity of curcumin with methotrexate in ameliorating Freund\u2019s complete adjuvant-induced arthritis with reduced hepatotoxicity in experimental animals. Eur J Pharmacol 668(1\u20132):293\u2013298","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1844_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","volume":"233","author":"B Bartok","year":"2010","unstructured":"Bartok B, Firestein GS (2010) Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 233(1):233\u2013255","journal-title":"Immunol Rev"},{"issue":"6","key":"1844_CR17","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.3390\/molecules16064567","volume":"16","author":"P Basnet","year":"2011","unstructured":"Basnet P, Skalko-Basnet N (2011) Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 16(6):4567\u20134598","journal-title":"Molecules"},{"issue":"6","key":"1844_CR18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrd2060","volume":"5","author":"JA Baur","year":"2006","unstructured":"Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5(6):493\u2013506","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"1844_CR19","first-page":"1532","volume":"25","author":"R Bhandari","year":"2020","unstructured":"Bhandari R et al (2020a) Nanocarrier-based approaches for the delivery of berberine: current advancements and future perspectives. Drug Discov Today 25(8):1532\u20131544","journal-title":"Drug Discov Today"},{"issue":"8","key":"1844_CR20","first-page":"693","volume":"15","author":"R Bhandari","year":"2020","unstructured":"Bhandari R et al (2020b) Berberine-loaded solid lipid nanoparticles for joint targeting in rheumatoid arthritis. Nanomedicine 15(8):693\u2013711","journal-title":"Nanomedicine"},{"issue":"12","key":"1844_CR21","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1136\/annrheumdis-2015-208476","volume":"75","author":"M Biniecka","year":"2016","unstructured":"Biniecka M et al (2016) Dysregulated bioenergetics: a key regulator of joint inflammation. Ann Rheum Dis 75(12):2192\u20132200","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1844_CR22","first-page":"645","volume":"45","author":"KM Bone","year":"2006","unstructured":"Bone KM, Wilkinson JM (2006) Herbal medicine for the treatment of rheumatoid arthritis: a systematic review. Rheumatology (Oxford) 45(5):645\u2013651","journal-title":"Rheumatology (Oxford)"},{"issue":"23","key":"1844_CR23","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1101\/gad.1256804","volume":"18","author":"J Brugarolas","year":"2004","unstructured":"Brugarolas J et al (2004) Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1\/TSC2 tumor suppressor complex. Genes Dev 18(23):2893\u20132904","journal-title":"Genes Dev"},{"issue":"6","key":"1844_CR24","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1194\/jlr.M600020-JLR200","volume":"47","author":"JM Brusq","year":"2006","unstructured":"Brusq JM et al (2006) Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine. J Lipid Res 47(6):1281\u20131288","journal-title":"J Lipid Res"},{"key":"1844_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-017-1303-3","volume":"19","author":"MF Bustamante","year":"2017","unstructured":"Bustamante MF et al (2017) Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther 19:1\u20132","journal-title":"Arthritis Res Ther"},{"issue":"16","key":"1844_CR26","doi-asserted-by":"publisher","first-page":"12587","DOI":"10.3390\/ijms241612587","volume":"24","author":"NA Cacciola","year":"2023","unstructured":"Cacciola NA et al (2023) An overview of the enhanced effects of curcumin and chemotherapeutic agents in combined cancer treatments. Int J Mol Sci 24(16):12587","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1844_CR27","first-page":"789","volume":"39","author":"Y Cao","year":"2020","unstructured":"Cao Y et al (2020) Role of mTOR signaling in the regulation of cytokine production in rheumatoid arthritis synovium. Clin Rheumatol 39(3):789\u2013798","journal-title":"Clin Rheumatol"},{"issue":"11","key":"1844_CR28","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/0006-2952(95)00171-U","volume":"49","author":"MMY Chan","year":"1995","unstructured":"Chan MMY (1995) Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol 49(11):1551\u20131556","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"1844_CR29","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1002\/ptr.4639","volume":"26","author":"B Chandran","year":"2012","unstructured":"Chandran B, Goel A (2012) A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res 26(11):1719\u20131725","journal-title":"Phytother Res"},{"issue":"2","key":"1844_CR30","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1208\/s12249-011-9632-z","volume":"12","author":"W Chen","year":"2011","unstructured":"Chen W et al (2011) Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats. AAPS PharmSciTech 12(2):705\u2013711","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"1844_CR31","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S1567-5769(00)00033-3","volume":"17","author":"Z Chen","year":"2013","unstructured":"Chen Z et al (2013) Epigallocatechin-3-gallate inhibits proliferation and cytokine production in fibroblast-like synoviocytes of rheumatoid arthritis by suppressing mTOR pathway. Int Immunopharmacol 17(2):229\u2013235","journal-title":"Int Immunopharmacol"},{"key":"1844_CR32","first-page":"961","volume":"109","author":"S Chen","year":"2019","unstructured":"Chen S et al (2019a) Curcumin ameliorates rheumatoid arthritis via inhibiting mTOR pathway activation in synovial fibroblasts. Biomed Pharmacother 109:961\u2013969","journal-title":"Biomed Pharmacother"},{"key":"1844_CR33","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.3389\/fimmu.2019.01806","volume":"10","author":"W Chen","year":"2019","unstructured":"Chen W et al (2019b) Epigallocatechin gallate suppresses Th17 cell differentiation through blocking mTOR signaling and promotes Treg cell development in autoimmune arthritis. Front Immunol 10:1806","journal-title":"Front Immunol"},{"key":"1844_CR34","first-page":"390","volume":"163","author":"Y Chen","year":"2019","unstructured":"Chen Y et al (2019c) Curcumin regulates Treg\/Th17 balance via mTOR signaling in experimental autoimmune arthritis. Biochem Pharmacol 163:390\u2013399","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"1844_CR35","first-page":"531","volume":"29","author":"Y Chen","year":"2021","unstructured":"Chen Y, Liu P, Gao X, Xu Y (2021) Quercetin inhibits inflammatory responses in rheumatoid arthritis through suppression of Th17 differentiation and mTOR pathway. Inflammopharmacology 29(2):531\u2013540","journal-title":"Inflammopharmacology"},{"key":"1844_CR36","volume":"592","author":"H Choudhury","year":"2021","unstructured":"Choudhury H et al (2021) Phytosomes: an advanced herbal drug delivery system for herbal extracts. Int J Pharm 592:120116","journal-title":"Int J Pharm"},{"issue":"12","key":"1844_CR37","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1056\/NEJM200103223441207","volume":"344","author":"EH Choy","year":"2001","unstructured":"Choy EH, Panayi GS (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. New Eng J Med 344(12):907\u2013916","journal-title":"New Eng J Med"},{"issue":"1","key":"1844_CR38","first-page":"201","volume":"12","author":"P Chunarkar-Patil","year":"2024","unstructured":"Chunarkar-Patil P et al (2024) Anticancer drug discovery based on natural products: from computational approaches to clinical studies. Biomedicine 12(1):201","journal-title":"Biomedicine"},{"key":"1844_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-3-319-41334-1_2","volume":"928","author":"AFG Cicero","year":"2016","unstructured":"Cicero AFG, Baggioni A (2016) Berberine and its role in chronic disease. Adv Exp Med Biol 928:27\u201345","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"1844_CR40","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.4049\/jimmunol.176.5.2730","volume":"176","author":"S Colombetti","year":"2006","unstructured":"Colombetti S et al (2006) Prolonged TCR\/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin. J Immunol 176(5):2730\u20132738","journal-title":"J Immunol"},{"issue":"3","key":"1844_CR41","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jnutbio.2014.11.008","volume":"26","author":"WI Col\u00f3n-Cesario","year":"2015","unstructured":"Col\u00f3n-Cesario WI et al (2015) Quercetin blocks the inflammatory response in human macrophages and neutrophils. J Nutr Biochem 26(3):293\u2013302","journal-title":"J Nutr Biochem"},{"key":"1844_CR42","doi-asserted-by":"publisher","first-page":"11612","DOI":"10.7554\/eLife.11612","volume":"5","author":"AJ Covarrubias","year":"2016","unstructured":"Covarrubias AJ et al (2016) Akt-mTORC1 signaling regulates acly to integrate metabolic input to control of macrophage activation. Elife 5:11612","journal-title":"Elife"},{"issue":"5","key":"1844_CR43","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/art.39031","volume":"67","author":"AP Cribbs","year":"2015","unstructured":"Cribbs AP, Kennedy A, Penn H et al (2015) Methotrexate restores regulatory T cell function through demethylation of the FoxP3 upstream enhancer in patients with rheumatoid arthritis. Arthritis Rheumatol 67(5):1182\u20131192","journal-title":"Arthritis Rheumatol"},{"key":"1844_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-016-1156-1","volume":"18","author":"AP Croft","year":"2016","unstructured":"Croft AP et al (2016) Rheumatoid synovial fibroblasts differentiate into distinct subsets in the presence of cytokines and cartilage. Arthritis Res Ther 18:1\u201311","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"1844_CR45","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1124\/pr.57.2.3","volume":"57","author":"BN Cronstein","year":"2005","unstructured":"Cronstein BN (2005) Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis. Pharmacol Rev 57(2):163\u2013172","journal-title":"Pharmacol Rev"},{"key":"1844_CR46","unstructured":"Indian Patent Application IN202111053474 (2021) Curcumin-loaded SLNs for targeted delivery in rheumatoid arthritis. Indian Patent Office"},{"key":"1844_CR47","doi-asserted-by":"crossref","unstructured":"Dai Q, Zhou D, Xu L, Song X (2018) Curcumin alleviates rheumatoid arthritis-induced inflammation and synovial hyperplasia by targeting mTOR pathway in rats. Drug Des Devel Ther 4095\u20134105","DOI":"10.2147\/DDDT.S175763"},{"key":"1844_CR48","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.fitote.2015.09.018","volume":"106","author":"G D'Andrea","year":"2015","unstructured":"D\u2019Andrea G (2015) Quercetin: a flavonol with multifaceted therapeutic applications? Fitoterapia 106:256\u2013271","journal-title":"Fitoterapia"},{"issue":"6","key":"1844_CR49","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.immuni.2009.04.014","volume":"30","author":"GM Delgoffe","year":"2009","unstructured":"Delgoffe GM et al (2009) The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 30(6):832\u2013844","journal-title":"Immunity"},{"key":"1844_CR50","volume":"85","author":"Y Deng","year":"2021","unstructured":"Deng Y et al (2021) Synergistic anti-arthritic effect of luteolin and methotrexate through modulating oxidative stress and cytokine responses. Phytomed 85:153540","journal-title":"Phytomed"},{"key":"1844_CR51","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s40265-017-0835-9","volume":"77","author":"S Dhillon","year":"2017","unstructured":"Dhillon S (2017) Tofacitinib: a review in rheumatoid arthritis. Drugs 77:1987\u20132001","journal-title":"Drugs"},{"issue":"30","key":"1844_CR52","doi-asserted-by":"publisher","first-page":"50284","DOI":"10.18632\/oncotarget.17466","volume":"8","author":"T Efferth","year":"2017","unstructured":"Efferth T et al (2017) Integration of phytochemicals and phytotherapy into cancer precision medicine. Oncotarget 8(30):50284","journal-title":"Oncotarget"},{"key":"1844_CR53","unstructured":"Indian Patent Application IN201941012118 (2020) EGCG nanoparticles targeting mTOR\/NF-\u03baB in autoimmune conditions. Indian Patent Office"},{"issue":"Suppl 1","key":"1844_CR54","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1289\/ehp.01109s169","volume":"109","author":"DS Fabricant","year":"2001","unstructured":"Fabricant DS, Farnsworth NR (2001) The value of plants used in traditional medicine for drug discovery. Environ Health Perspect 109(Suppl 1):69\u201375","journal-title":"Environ Health Perspect"},{"issue":"4","key":"1844_CR55","first-page":"1605","volume":"43","author":"L Fang","year":"2017","unstructured":"Fang L et al (2017) Pristimerin induces apoptosis and autophagy by inhibiting PI3K\/Akt\/mTOR pathway in rheumatoid arthritis synovial fibroblasts. Cell Physiol Biochem 43(4):1605\u20131615","journal-title":"Cell Physiol Biochem"},{"issue":"1\u20132","key":"1844_CR56","first-page":"18","volume":"444","author":"J Feng","year":"2013","unstructured":"Feng J et al (2013) Liposomal gambogic acid formulation: preparation, characterization, and anti-tumor activity. Int J Pharm 444(1\u20132):18\u201325","journal-title":"Int J Pharm"},{"issue":"1","key":"1844_CR57","doi-asserted-by":"publisher","first-page":"14852","DOI":"10.1038\/ncomms14852","volume":"8","author":"M Frank-Bertoncelj","year":"2017","unstructured":"Frank-Bertoncelj M et al (2017) Epigenetically-driven anatomical diversity of synovial fibroblasts guides joint-specific fibroblast functions. Nat Commun 8(1):14852","journal-title":"Nat Commun"},{"issue":"18","key":"1844_CR58","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1016\/j.cub.2006.08.001","volume":"16","author":"MA Frias","year":"2006","unstructured":"Frias MA et al (2006) mSin1 is necessary for Akt\/PKB phosphorylation, and its isoforms define three distinct mTORC2s. Curr Biol 16(18):1865\u20131870","journal-title":"Curr Biol"},{"issue":"3","key":"1844_CR59","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jbspin.2018.07.004","volume":"86","author":"B Friedman","year":"2019","unstructured":"Friedman B, Cronstein B (2019) Methotrexate mechanism in treatment of rheumatoid arthritis. Joint Bone Spine 86(3):301\u2013307","journal-title":"Joint Bone Spine"},{"issue":"4","key":"1844_CR60","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","volume":"170","author":"DA Fruman","year":"2017","unstructured":"Fruman DA et al (2017) The PI3K pathway in human disease. Cell 170(4):605\u2013635","journal-title":"Cell"},{"issue":"7","key":"1844_CR61","first-page":"1614","volume":"68","author":"R Garcia-Carbonell","year":"2016","unstructured":"Garcia-Carbonell R et al (2016) Critical role of glucose metabolism in rheumatoid arthritis fibroblast-like synoviocytes. A&r 68(7):1614\u20131626","journal-title":"A&r"},{"issue":"2","key":"1844_CR62","first-page":"101","volume":"22","author":"ST Gilani","year":"2012","unstructured":"Gilani ST et al (2012) Adverse effects of low dose methotrexate in rheumatoid arthritis patients. J Coll Physicians Surg Pak 22(2):101\u2013104","journal-title":"J Coll Physicians Surg Pak"},{"issue":"4","key":"1844_CR63","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.bcp.2007.08.016","volume":"75","author":"A Goel","year":"2008","unstructured":"Goel A, Kunnumakkara AB, Aggarwal BB (2008) Curcumin as \u201ccurecumin\u201d: from kitchen to clinic. Biochem Pharmacol 75(4):787\u2013809","journal-title":"Biochem Pharmacol"},{"key":"1844_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.prmcm.2024.100444","volume":"11","author":"S Goswami","year":"2024","unstructured":"Goswami S et al (2024) Pharmacological significance of Catharanthus roseus in cancer management: a review. Pharmacol Res-Mod Chin Med 11:100444","journal-title":"Pharmacol Res-Mod Chin Med"},{"issue":"7","key":"1844_CR65","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1136\/annrheumdis-2014-205696","volume":"74","author":"M Guma","year":"2015","unstructured":"Guma M et al (2015) Choline kinase inhibition in rheumatoid arthritis. Ann Rheum Dis 74(7):1399\u20131407","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1844_CR66","first-page":"650","volume":"25","author":"Y Guo","year":"2011","unstructured":"Guo Y et al (2011) Drug\u2013herb interaction between berberine and simvastatin: a bioavailability and pharmacokinetics study in rats. Phytother Res 25(5):650\u2013655","journal-title":"Phytother Res"},{"issue":"1","key":"1844_CR67","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41413-018-0016-9","volume":"6","author":"Q Guo","year":"2018","unstructured":"Guo Q et al (2018) Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res 6(1):15","journal-title":"Bone Res"},{"key":"1844_CR68","first-page":"393","volume":"17","author":"P Gupta","year":"2022","unstructured":"Gupta P, Bajpai VK, Kim IH (2022) Nanoformulations of phytoconstituents targeting mTOR pathway: promising therapeutics for rheumatoid arthritis. Int J Nanomed 17:393\u2013412","journal-title":"Int J Nanomed"},{"issue":"2","key":"1844_CR69","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","volume":"30","author":"DM Gwinn","year":"2008","unstructured":"Gwinn DM et al (2008) AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 30(2):214\u2013226","journal-title":"Mol Cell"},{"issue":"4","key":"1844_CR70","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1038\/ijo.2008.116","volume":"32","author":"DG Hardie","year":"2008","unstructured":"Hardie DG (2008) AMPK: a key regulator of energy balance in the single cell and the whole organism. Int J Obes 32(4):S7\u2013S12","journal-title":"Int J Obes"},{"issue":"18","key":"1844_CR71","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1101\/gad.17420111","volume":"25","author":"DG Hardie","year":"2011","unstructured":"Hardie DG (2011) AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev 25(18):1895\u20131908","journal-title":"Genes Dev"},{"key":"1844_CR72","volume":"193","author":"Y He","year":"2020","unstructured":"He Y et al (2020) Celastrol-loaded polymeric micelles with enhanced therapeutic efficacy in rheumatoid arthritis. Colloids Surf B Biointerfaces 193:111125","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"10","key":"1844_CR73","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/foods6100092","volume":"6","author":"SJ Hewlings","year":"2017","unstructured":"Hewlings SJ, Kalman DS (2017) Curcumin: a review of its effects on human health. Foods 6(10):92","journal-title":"Foods"},{"issue":"9","key":"1844_CR74","first-page":"1274","volume":"83","author":"YC Hou","year":"2012","unstructured":"Hou YC et al (2012) Inhibitory effect of artemisinin on NF-\u03baB activation in murine macrophage cells. Biochem Pharmacol 83(9):1274\u20131285","journal-title":"Biochem Pharmacol"},{"key":"1844_CR75","first-page":"1","volume":"2020","author":"Y Hu","year":"2020","unstructured":"Hu Y, Davies GE (2020) Berberine inhibits adipogenesis in high-fat diet-induced obesity mice through down-regulation of PPAR\u03b3 via the AMPK\/mTOR pathway. Int J Endocrinol 2020:1\u20139","journal-title":"Int J Endocrinol"},{"issue":"1","key":"1844_CR76","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s13075-019-2014-8","volume":"21","author":"C Hu","year":"2019","unstructured":"Hu C, Zhang X, Zheng Q, Shen W, Liu Z (2019a) Celastrol induces autophagy and apoptosis via the ROS\/JNK\/mTOR axis in RA synoviocytes. Arthritis Res Ther 21(1):239","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"1844_CR77","first-page":"444","volume":"18","author":"F Hu","year":"2019","unstructured":"Hu F et al (2019b) mTOR signaling pathway in autoimmune diseases. Autoimmun Rev 18(5):444\u2013454","journal-title":"Autoimmun Rev"},{"issue":"1","key":"1844_CR78","first-page":"350","volume":"35","author":"W Hu","year":"2021","unstructured":"Hu W et al (2021) Luteolin modulates the inflammatory response through the PI3K\/Akt\/mTOR pathway in lipopolysaccharide-stimulated macrophages. Phytother Res 35(1):350\u2013361","journal-title":"Phytother Res"},{"issue":"3","key":"1844_CR79","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.molcel.2014.12.013","volume":"57","author":"R Huang","year":"2015","unstructured":"Huang R et al (2015) Deacetylation of nuclear LC3 drives autophagy initiation under starvation. Mol Cell 57(3):456\u2013466","journal-title":"Mol Cell"},{"key":"1844_CR80","volume":"941","author":"C Huang","year":"2023","unstructured":"Huang C, Wang J, Shen Y, Zheng X (2023) Quercetin enhances the anti-inflammatory effect of rapamycin via regulation of NF-\u03baB and mTOR in experimental arthritis. Eur J Pharmacol 941:175502","journal-title":"Eur J Pharmacol"},{"key":"1844_CR81","doi-asserted-by":"crossref","unstructured":"Huang Y et al (2016) Chemical changes of bioactive phytochemicals during thermal processing. 2016:9","DOI":"10.1016\/B978-0-08-100596-5.03055-9"},{"issue":"11","key":"1844_CR82","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/ptr.5693","volume":"30","author":"M Imenshahidi","year":"2016","unstructured":"Imenshahidi M, Hosseinzadeh H (2016) Berberis vulgaris and berberine: an update review. Phytother Res 30(11):1745\u20131764","journal-title":"Phytother Res"},{"key":"1844_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108612","volume":"112","author":"M Imran","year":"2019","unstructured":"Imran M et al (2019) Luteolin, a flavonoid, as an anticancer agent: a review. Biomed Pharmacother 112:108612","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"1844_CR84","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3390\/nu13020408","volume":"13","author":"M Jabczyk","year":"2021","unstructured":"Jabczyk M et al (2021) Curcumin and autoimmune diseases: therapeutic effects and mechanisms of action. Nutrients 13(2):408","journal-title":"Nutrients"},{"issue":"1","key":"1844_CR85","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10875-006-9066-7","volume":"27","author":"GC Jagetia","year":"2007","unstructured":"Jagetia GC, Aggarwal BB (2007a) \u201cSpicing up\u201d of the immune system by curcumin. J Clin Immunol 27(1):19\u201335","journal-title":"J Clin Immunol"},{"issue":"1","key":"1844_CR86","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10875-006-9066-7","volume":"27","author":"GC Jagetia","year":"2007","unstructured":"Jagetia GC, Aggarwal BB (2007b) Spicing up\" of the immune system by curcumin. J Clin Immunol 27(1):19\u201335","journal-title":"J Clin Immunol"},{"issue":"4","key":"1844_CR87","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3109\/10717544.2014.975382","volume":"23","author":"A Jain","year":"2016","unstructured":"Jain A et al (2016) Formulation development and characterization of curcumin phytosome for arthritis. Drug Deliv 23(4):1326\u20131334","journal-title":"Drug Deliv"},{"issue":"21","key":"1844_CR88","doi-asserted-by":"publisher","first-page":"7534","DOI":"10.1073\/pnas.0802865105","volume":"105","author":"S Jang","year":"2008","unstructured":"Jang S, Kelley KW, Johnson RW (2008) Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1. Proc Natl Acad Sci USA 105(21):7534\u20137539","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1844_CR89","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12906-018-2235-4","volume":"18","author":"Y Jia","year":"2018","unstructured":"Jia Y et al (2018) Hepatoprotective effects of Tripterygium glycosides in combination with methotrexate in RA patients. BMC Complement Altern Med 18(1):170","journal-title":"BMC Complement Altern Med"},{"key":"1844_CR90","volume":"82","author":"R Jia","year":"2020","unstructured":"Jia R et al (2020) Astragaloside IV attenuates collagen-induced arthritis by modulating the balance of Treg and Th17 cells and inhibiting mTOR pathway. Int Immunopharmacol 82:106330","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"1844_CR91","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1002\/mnfr.201100117","volume":"55","author":"JJ Johnson","year":"2011","unstructured":"Johnson JJ et al (2011) Enhancing the bioavailability of resveratrol by combining it with piperine. Mol Nutr Food Res 55(8):1169\u20131176","journal-title":"Mol Nutr Food Res"},{"key":"1844_CR92","volume":"139","author":"N Kalra","year":"2021","unstructured":"Kalra N et al (2021) Quercetin-loaded chitosan nanoparticles ameliorate adjuvant-induced arthritis via inhibition of mTOR\/NF-\u03baB pathway. Biomed Pharmacother 139:111623","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"1844_CR93","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a000141","volume":"1","author":"M Karin","year":"2009","unstructured":"Karin M (2009) NF-\u03baB as a critical link between inflammation and cancer. Cold Spring Harb Perspect Biol 1(5):a000141","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"7","key":"1844_CR94","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1016\/j.celrep.2018.04.044","volume":"23","author":"T Karonitsch","year":"2018","unstructured":"Karonitsch T et al (2018) mTOR senses environmental cues to shape the fibroblast-like synoviocyte response to inflammation. Cell Rep 23(7):2157\u20132167","journal-title":"Cell Rep"},{"issue":"4","key":"1844_CR95","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.4049\/jimmunol.1202683","volume":"190","author":"K Katholnig","year":"2013","unstructured":"Katholnig K et al (2013) p38\u03b1 senses environmental stress to control innate immune responses via mechanistic target of rapamycin. J Immunol 190(4):1519\u20131527","journal-title":"J Immunol"},{"issue":"42","key":"1844_CR96","doi-asserted-by":"publisher","first-page":"18085","DOI":"10.1073\/pnas.1010560107","volume":"107","author":"SD Katzman","year":"2010","unstructured":"Katzman SD et al (2010) Duration of antigen receptor signaling determines T-cell tolerance or activation. Proc Natl Acad Sci USA 107(42):18085\u201318090","journal-title":"Proc Natl Acad Sci USA"},{"key":"1844_CR97","volume":"157","author":"H Khan","year":"2020","unstructured":"Khan H et al (2020) Therapeutic potential of quercetin in autoimmune diseases. Pharmacol Res 157:104895","journal-title":"Pharmacol Res"},{"issue":"11","key":"1844_CR98","first-page":"889","volume":"16","author":"A Khurana","year":"2021","unstructured":"Khurana A et al (2021) Resveratrol-loaded lipid nanoparticles enhance therapeutic activity in murine model of arthritis. Nanomedicine 16(11):889\u2013901","journal-title":"Nanomedicine"},{"issue":"1","key":"1844_CR99","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41556-018-0205-1","volume":"21","author":"J Kim","year":"2019","unstructured":"Kim J, Guan KL (2019) mTOR as a central hub of nutrient signaling and cell growth. Nat Cell Biol 21(1):63\u201371","journal-title":"Nat Cell Biol"},{"issue":"5","key":"1844_CR100","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0006-2952(99)00160-4","volume":"58","author":"HK Kim","year":"1999","unstructured":"Kim HK, Cheon BS, Kim YH, Kim SY, Kim HP (1999) Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships. Biochem Pharmacol 58(5):759\u2013765","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"1844_CR101","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.3945\/jn.108.089912","volume":"138","author":"HR Kim","year":"2008","unstructured":"Kim HR et al (2008a) Green tea protects rats against autoimmune arthritis by modulating disease-related immune events. J Nutr 138(11):2111\u20132116","journal-title":"J Nutr"},{"issue":"3","key":"1844_CR102","first-page":"839","volume":"326","author":"HR Kim","year":"2008","unstructured":"Kim HR et al (2008b) Luteolin inhibits proliferation and affects the function of stimulated rat synovial fibroblasts. J Pharmacol Exp Ther 326(3):839\u2013846","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"1844_CR103","first-page":"285","volume":"23","author":"DS Kim","year":"2013","unstructured":"Kim DS et al (2013a) Curcumin attenuates methotrexate-induced hepatotoxicity via antioxidant activity in rats. Toxicol Mech Methods 23(4):285\u2013291","journal-title":"Toxicol Mech Methods"},{"issue":"9","key":"1844_CR104","first-page":"1531","volume":"87","author":"YS Kim","year":"2013","unstructured":"Kim YS et al (2013b) Curcumin ameliorates methotrexate-induced hepatic damage in rats. Arch Toxicol 87(9):1531\u20131540","journal-title":"Arch Toxicol"},{"issue":"3","key":"1844_CR105","first-page":"845","volume":"153","author":"SH Kim","year":"2014","unstructured":"Kim SH, Choi KC, Jeung EB (2014) Evaluation of the effects of licorice extracts on cytochrome P450 isoenzymes. J Ethnopharmacol 153(3):845\u2013853","journal-title":"J Ethnopharmacol"},{"issue":"8","key":"1844_CR106","first-page":"1319","volume":"54","author":"EK Kim","year":"2015","unstructured":"Kim EK et al (2015) IL-23 induces SIRT1 expression to suppress Foxp3+ regulatory T cells and aggravate arthritis in mice. Rheumatology (Oxford) 54(8):1319\u20131329","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"1844_CR107","first-page":"5629","volume":"119","author":"SJ Kim","year":"2018","unstructured":"Kim SJ et al (2018) Resveratrol regulates AMPK-dependent autophagy and inhibits mTOR signaling in rheumatoid arthritis synovial fibroblasts. J Cell Biochem 119(7):5629\u20135637","journal-title":"J Cell Biochem"},{"issue":"9","key":"1844_CR108","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.3390\/cells9092073","volume":"9","author":"JM Kim","year":"2020","unstructured":"Kim JM et al (2020) Osteoblast-osteoclast communication and bone homeostasis. Cells 9(9):2073","journal-title":"Cells"},{"issue":"3","key":"1844_CR109","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.immuni.2014.08.011","volume":"41","author":"T Kobayashi","year":"2014","unstructured":"Kobayashi T et al (2014) The histidine transporter SLC15A4 coordinates mTOR-dependent inflammatory responses and pathogenic antibody production. Immun 41(3):375\u2013388","journal-title":"Immun"},{"issue":"4","key":"1844_CR110","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.tips.2015.02.001","volume":"36","author":"MI Koenders","year":"2015","unstructured":"Koenders MI, Van den Berg WB (2015) Novel therapeutic targets in rheumatoid arthritis. Trends Pharmacol Sci 36(4):189\u2013195","journal-title":"Trends Pharmacol Sci"},{"key":"1844_CR111","volume":"92","author":"M Kundu","year":"2021","unstructured":"Kundu M et al (2021) Targeting mTOR signaling pathway by natural products for cancer and inflammation. Phytomedicine 92:153751","journal-title":"Phytomedicine"},{"issue":"12","key":"1844_CR112","first-page":"2267","volume":"35","author":"JD Lambert","year":"2007","unstructured":"Lambert JD et al (2007) Pharmacokinetics and bioavailability of EGCG in humans. Drug Metab Dispos 35(12):2267\u20132272","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"1844_CR113","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149(2):274\u2013293","journal-title":"Cell"},{"key":"1844_CR114","doi-asserted-by":"crossref","unstructured":"Laporte JR et al (2004) Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents. Drug Saf 411\u2013420","DOI":"10.2165\/00002018-200427060-00005"},{"key":"1844_CR115","doi-asserted-by":"publisher","first-page":"352","DOI":"10.2119\/molmed.2010.00049","volume":"16","author":"T Laragione","year":"2010","unstructured":"Laragione T, Gulko PS (2010) mTOR regulates the invasive properties of synovial fibroblasts in rheumatoid arthritis. Mol Med 16:352\u2013358","journal-title":"Mol Med"},{"key":"1844_CR116","first-page":"39","volume":"30","author":"JY Lee","year":"2017","unstructured":"Lee JY et al (2017) Celastrol suppresses IL-6 and IL-17 production in PBMCs from RA patients by modulating NF-\u03baB and mTOR signaling. Phytomedicine 30:39\u201346","journal-title":"Phytomedicine"},{"issue":"1","key":"1844_CR117","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12967-019-1812-8","volume":"17","author":"SY Lee","year":"2019","unstructured":"Lee SY et al (2019) Methotrexate inhibits differentiation of Th17 cells by interfering with the mTOR pathway. J Transl Med 17(1):68","journal-title":"J Transl Med"},{"key":"1844_CR118","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s10198-012-0431-6","volume":"14","author":"I Lekander","year":"2013","unstructured":"Lekander I et al (2013) The cost-effectiveness of TNF-inhibitors for the treatment of rheumatoid arthritis in Swedish clinical practice. Eur J Health Econ 14:863\u2013873","journal-title":"Eur J Health Econ"},{"issue":"5","key":"1844_CR119","first-page":"1068","volume":"29","author":"J Li","year":"2017","unstructured":"Li J, Weng JK (2017) Demystifying plant natural product drug discovery. Plant Cell 29(5):1068\u20131074","journal-title":"Plant Cell"},{"issue":"6","key":"1844_CR120","first-page":"584","volume":"22","author":"W Li","year":"2015","unstructured":"Li W et al (2015) EGCG induces apoptosis and autophagy through inhibition of mTOR signaling in fibroblast-like synoviocytes from rheumatoid arthritis patients. Phytomed 22(6):584\u2013591","journal-title":"Phytomed"},{"issue":"3","key":"1844_CR121","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3390\/nu8030167","volume":"8","author":"Y Li","year":"2016","unstructured":"Li Y et al (2016) Quercetin, Inflammation and Immunity. Nutrients 8(3):167","journal-title":"Nutrients"},{"key":"1844_CR122","first-page":"129","volume":"69","author":"J Li","year":"2019","unstructured":"Li J et al (2019a) EGCG suppresses the expression of IL-6 and TNF-\u03b1 in collagen-induced arthritis rats via inhibition of the PI3K\/Akt\/mTOR pathway. Int Immunopharmacol 69:129\u2013135","journal-title":"Int Immunopharmacol"},{"key":"1844_CR123","first-page":"1345","volume":"13","author":"L Li","year":"2019","unstructured":"Li L et al (2019b) Chitosan-coated liposomes for enhanced delivery of Astragalus flavonoids against rheumatoid arthritis. Drug Deats Dev Ther 13:1345\u20131355","journal-title":"Drug Deats Dev Ther"},{"key":"1844_CR124","first-page":"3105","volume":"14","author":"Y Li","year":"2019","unstructured":"Li Y et al (2019c) PEGylated gambogic acid prodrug micelles: enhanced stability, bioavailability and anti-tumor efficacy. Int J Nanomed 14:3105\u20133116","journal-title":"Int J Nanomed"},{"key":"1844_CR125","volume":"259","author":"C Li","year":"2020","unstructured":"Li C et al (2020a) Kaempferitrin Reduces Oxidative Stress and Inflammation in RA via the Keap1\/Nrf2 and PI3K\/Akt\/mTOR Pathways. J Ethnopharmacol 259:112932","journal-title":"J Ethnopharmacol"},{"key":"1844_CR126","first-page":"672","volume":"148","author":"X Li","year":"2020","unstructured":"Li X et al (2020b) Chitosan-based delivery system for luteolin: Enhanced anti-inflammatory effect and improved bioavailability. Int J Biol Macromol 148:672\u2013681","journal-title":"Int J Biol Macromol"},{"key":"1844_CR127","volume":"121","author":"X Li","year":"2020","unstructured":"Li X et al (2020c) Curcumin induces autophagy and inhibits proliferation and invasion through Akt\/mTOR signaling pathway in rheumatoid arthritis fibroblast-like synoviocytes. Biomed Pharmacother 121:109641","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1844_CR128","first-page":"52","volume":"40","author":"X Li","year":"2020","unstructured":"Li X et al (2020d) Curcumin inhibits fibroblast-like synoviocyte proliferation and invasion via the suppression of PI3K\/AKT\/mTOR signaling pathway. J Tradit Chin Med 40(1):52\u201358","journal-title":"J Tradit Chin Med"},{"key":"1844_CR129","volume":"84","author":"X Li","year":"2020","unstructured":"Li X et al (2020e) Gambogic acid promotes autophagy and alleviates inflammation in rheumatoid arthritis by targeting mTOR signaling. Int Immunopharmacol 84:106527","journal-title":"Int Immunopharmacol"},{"key":"1844_CR130","volume":"68","author":"Y Li","year":"2020","unstructured":"Li Y et al (2020f) Epigallocatechin-3-gallate inhibits rheumatoid arthritis fibroblast-like synoviocytes via suppression of the mTOR pathway and promotion of autophagy. Phytomedicine 68:153172","journal-title":"Phytomedicine"},{"key":"1844_CR131","volume":"12","author":"C Li","year":"2021","unstructured":"Li C et al (2021a) Artesunate ameliorates rheumatoid arthritis by suppressing NF-\u03baB and mTOR signaling pathways in collagen-induced arthritis rats. Front Pharmacol 12:653196","journal-title":"Front Pharmacol"},{"key":"1844_CR132","volume":"279","author":"J Li","year":"2021","unstructured":"Li J et al (2021b) Total saponins from Rhizoma Panacis Majoris alleviate synovial inflammation in adjuvant-induced arthritis via suppressing PI3K\/Akt\/mTOR pathway. J Ethnopharmacol 279:114345","journal-title":"J Ethnopharmacol"},{"issue":"5","key":"1844_CR133","first-page":"2724","volume":"35","author":"W Li","year":"2021","unstructured":"Li W et al (2021c) Quercetin inhibits proliferation and inflammation of fibroblast-like synoviocytes by targeting mTOR signaling in rheumatoid arthritis. Phytother Res 35(5):2724\u20132734","journal-title":"Phytother Res"},{"issue":"3","key":"1844_CR134","first-page":"1357","volume":"36","author":"Y Li","year":"2022","unstructured":"Li Y et al (2022) Effectiveness and safety of berberine in the treatment of rheumatoid arthritis: a systematic review and meta-analysis. Phytother Res 36(3):1357\u20131371","journal-title":"Phytother Res"},{"key":"1844_CR135","volume":"637","author":"Y Li","year":"2023","unstructured":"Li Y et al (2023) Galactosylated PLGA nanoparticles enhance oral delivery and anti-inflammatory efficacy of resveratrol by targeting SGLT1 and suppressing PI3K\/Akt\/mTOR signaling. Int J Pharm 637:122678","journal-title":"Int J Pharm"},{"key":"1844_CR136","first-page":"3251","volume":"16","author":"W Liao","year":"2021","unstructured":"Liao W et al (2021) Targeted delivery of pristimerin using folic acid-modified PLGA nanoparticles suppresses arthritis via enhanced modulation of synovial inflammation. Int J Nanomed 16:3251\u20133266","journal-title":"Int J Nanomed"},{"issue":"7","key":"1844_CR137","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2174\/156800908786241050","volume":"8","author":"Y Lin","year":"2008","unstructured":"Lin Y, Shi R, Wang X, Shen HM (2008) Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets 8(7):634\u2013646","journal-title":"Curr Cancer Drug Targets"},{"issue":"6","key":"1844_CR138","first-page":"3622","volume":"285","author":"Q Liu","year":"2010","unstructured":"Liu Q et al (2010) Identification of S6K1 as a direct target of resveratrol using in vitro kinase assays. J Biol Chem 285(6):3622\u20133630","journal-title":"J Biol Chem"},{"key":"1844_CR139","first-page":"2935","volume":"10","author":"Y Liu","year":"2015","unstructured":"Liu Y et al (2015a) PEGylated liposomes loaded with celastrol: enhanced stability and anti-arthritic efficacy in a murine model of arthritis. Int J Nanomed 10:2935\u20132944","journal-title":"Int J Nanomed"},{"issue":"6","key":"1844_CR140","first-page":"1443","volume":"36","author":"Y Liu","year":"2015","unstructured":"Liu Y et al (2015b) Pristimerin inhibits the proliferation and induces the apoptosis of rheumatoid arthritis fibroblast-like synoviocytes through the PI3K\/Akt\/mTOR pathway. Int J Mol Med 36(6):1443\u20131450","journal-title":"Int J Mol Med"},{"key":"1844_CR141","first-page":"273","volume":"118","author":"Y Liu","year":"2016","unstructured":"Liu Y et al (2016) Pharmacokinetics and tissue distribution of gambogic acid in rats using ultra-performance liquid chromatography with tandem mass spectrometry. J Pharm Biomed Anal 118:273\u2013279","journal-title":"J Pharm Biomed Anal"},{"issue":"2","key":"1844_CR142","first-page":"205","volume":"65","author":"L Liu","year":"2017","unstructured":"Liu L et al (2017a) The PI3K\/Akt\/mTOR pathway as a target for rheumatoid arthritis therapy. Immunol Res 65(2):205\u2013216","journal-title":"Immunol Res"},{"issue":"1","key":"1844_CR143","first-page":"1896","volume":"24","author":"Y Liu","year":"2017","unstructured":"Liu Y et al (2017b) Pharmacokinetics and bioavailability enhancement of astragaloside IV: from molecular basis to delivery systems. Drug Deliv 24(1):1896\u20131908","journal-title":"Drug Deliv"},{"key":"1844_CR144","volume":"59","author":"H Liu","year":"2019","unstructured":"Liu H et al (2019) Gambogic acid suppresses the proliferation and migration of fibroblast-like synoviocytes via inhibition of PI3K\/Akt\/mTOR signaling in rheumatoid arthritis. Phytomedicine 59:152783","journal-title":"Phytomedicine"},{"issue":"2","key":"1844_CR145","first-page":"1113","volume":"21","author":"Y Liu","year":"2020","unstructured":"Liu Y et al (2020a) Berberine reduces inflammation in a rat model of rheumatoid arthritis by inhibiting PI3K\/AKT\/mTOR signaling pathway. Mol Med Rep 21(2):1113\u20131120","journal-title":"Mol Med Rep"},{"issue":"10","key":"1844_CR146","first-page":"1682","volume":"46","author":"Y Liu","year":"2020","unstructured":"Liu Y et al (2020b) Development of luteolin-loaded solid lipid nanoparticles for oral delivery: improvement of bioavailability and anti-inflammatory effects. Drug Dev Ind Pharm 46(10):1682\u20131689","journal-title":"Drug Dev Ind Pharm"},{"issue":"8","key":"1844_CR147","first-page":"5141","volume":"3","author":"Y Liu","year":"2020","unstructured":"Liu Y et al (2020c) ROS-responsive artemisinin nanoformulation for effective rheumatoid arthritis therapy through regulation of inflammatory signaling. ACS Appl Bio Mater 3(8):5141\u20135152","journal-title":"ACS Appl Bio Mater"},{"issue":"1","key":"1844_CR148","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13075-021-02584-x","volume":"23","author":"H Liu","year":"2021","unstructured":"Liu H et al (2021a) Resveratrol attenuates inflammation and matrix degradation via the SIRT1\/NF-\u03baB pathway in human RA fibroblast-like synoviocytes. Arthritis Res Ther 23(1):203","journal-title":"Arthritis Res Ther"},{"key":"1844_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2021.108793","volume":"230","author":"S Liu","year":"2021","unstructured":"Liu S et al (2021b) Recent advances on signaling pathways and their inhibitors in rheumatoid arthritis. Clin Immunol 230:108793","journal-title":"Clin Immunol"},{"issue":"4","key":"1844_CR150","first-page":"2069","volume":"35","author":"Y Liu","year":"2021","unstructured":"Liu Y, Min W, Lin X, Zhang J, Dai L (2021c) Curcumin ameliorates rheumatoid arthritis through regulating Treg\/Th17 balance and inhibiting inflammatory cytokines via the mTOR pathway. Phytother Res 35(4):2069\u20132079","journal-title":"Phytother Res"},{"key":"1844_CR151","volume":"139","author":"Y Liu","year":"2021","unstructured":"Liu Y, Xu J, Zhang S, Zhang J, Sun X (2021d) Gambogic acid-induced autophagy mediates anti-inflammatory effects in collagen-induced arthritis via suppression of mTOR. Biomed Pharmacother 139:111616","journal-title":"Biomed Pharmacother"},{"key":"1844_CR152","volume":"11","author":"X Luo","year":"2020","unstructured":"Luo X et al (2020) Quercetin activates AMPK and promotes autophagy to alleviate inflammation in collagen-induced arthritis. Front Pharmacol 11:568408","journal-title":"Front Pharmacol"},{"key":"1844_CR153","volume":"92","author":"X Luo","year":"2021","unstructured":"Luo X et al (2021) Immunomodulatory effects of licorice flavonoids in RA via Th17\/Treg balance and mTOR inhibition. Int Immunopharmacol 92:107332","journal-title":"Int Immunopharmacol"},{"key":"1844_CR154","first-page":"613","volume":"17","author":"H Luo","year":"2022","unstructured":"Luo H et al (2022) Enhanced anti-arthritic effect of EGCG-loaded PLGA nanoparticles via targeted delivery and sustained release. Int J Nanomed 17:613\u2013627","journal-title":"Int J Nanomed"},{"issue":"8","key":"1844_CR155","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/ni.2936","volume":"15","author":"A Mar\u00e7ais","year":"2014","unstructured":"Mar\u00e7ais A et al (2014) The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells. Nat Immunol 15(8):749\u2013757","journal-title":"Nat Immunol"},{"issue":"1","key":"1844_CR156","doi-asserted-by":"publisher","first-page":"43165","DOI":"10.1038\/srep43165","volume":"7","author":"T McGarry","year":"2017","unstructured":"McGarry T et al (2017) Resolution of TLR2-induced inflammation through manipulation of metabolic pathways in rheumatoid arthritis. Sci Rep 7(1):43165","journal-title":"Sci Rep"},{"issue":"6","key":"1844_CR157","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","volume":"36","author":"MC Mendoza","year":"2011","unstructured":"Mendoza MC, Er EE, Blenis J (2011) The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. Trends Biochem Sci 36(6):320\u2013328","journal-title":"Trends Biochem Sci"},{"key":"1844_CR158","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3389\/fphar.2020.00633","volume":"11","author":"J Meng","year":"2020","unstructured":"Meng J et al (2020) Resveratrol alleviates collagen-induced arthritis via PI3K\/Akt\/mTOR signaling pathway in T cells. Front Pharmacol 11:1010","journal-title":"Front Pharmacol"},{"key":"1844_CR159","doi-asserted-by":"crossref","first-page":"7517","DOI":"10.2147\/IJN.S333657","volume":"16","author":"X Meng","year":"2021","unstructured":"Meng X et al (2021) Lipid-based nanoparticles encapsulating quercetin: preparation, characterization, and evaluation of anti-inflammatory effect in arthritis. Int J Nanomed 16:7517\u20137532","journal-title":"Int J Nanomed"},{"issue":"2","key":"1844_CR160","first-page":"336","volume":"522","author":"KJ Min","year":"2020","unstructured":"Min KJ, Um HJ, Cho KH, Kwon TK (2020) Quercetin suppresses induction of IL-1\u03b2 by inhibiting the mTOR pathway in rheumatoid arthritis fibroblast-like synoviocytes. Biochem Biophys Res Commun 522(2):336\u2013342","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1844_CR161","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cyto.2012.06.316","volume":"60","author":"A Mitra","year":"2012","unstructured":"Mitra A, Raychaudhuri SK, Raychaudhuri SP (2012) IL-22 induced cell proliferation is regulated by PI3K\/Akt\/mTOR signaling cascade. Cytokine 60(1):38\u201342","journal-title":"Cytokine"},{"issue":"1","key":"1844_CR162","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41467-018-02892-y","volume":"9","author":"F Mizoguchi","year":"2018","unstructured":"Mizoguchi F et al (2018) Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis. Nat Commun 9(1):789","journal-title":"Nat Commun"},{"issue":"6","key":"1844_CR163","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1517\/14740338.2013.823947","volume":"12","author":"G Murdaca","year":"2013","unstructured":"Murdaca G, Span\u00f2 F, Puppo F (2013) Use of leflunomide plus TNF-\u03b1 inhibitors in rheumatoid arthritis. Expert Opin Drug Saf 12(6):801\u2013804","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"1844_CR164","first-page":"76","volume":"17","author":"AB Nair","year":"2020","unstructured":"Nair AB et al (2020) Quercetin-loaded nanoparticles for the treatment of inflammatory diseases: enhanced bioavailability and targeted delivery. Curr Drug Deliv 17(1):76\u201383","journal-title":"Curr Drug Deliv"},{"issue":"5","key":"1844_CR165","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.immuni.2014.04.007","volume":"40","author":"M Nakaya","year":"2014","unstructured":"Nakaya M et al (2014) Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation. Immun 40(5):692\u2013705","journal-title":"Immun"},{"key":"1844_CR166","unstructured":"Indian Patent Application IN202241054327 (2022) Nanocarriers co-delivering resveratrol and leflunomide for targeted RA treatment. Indian Patent Office"},{"issue":"11","key":"1844_CR167","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.2174\/092986712799945085","volume":"19","author":"AR Neves","year":"2012","unstructured":"Neves AR, Lucio M, Lima JL, Reis S (2012) Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactions. Curr Med Chem 19(11):1663\u20131681","journal-title":"Curr Med Chem"},{"issue":"3","key":"1844_CR169","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","volume":"83","author":"DJ Newman","year":"2020","unstructured":"Newman DJ, Cragg GM (2020) Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019. J Nat Prod 83(3):770\u2013803","journal-title":"J Nat Prod"},{"key":"1844_CR170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-020-02354-1","volume":"22","author":"M Novella-Navarro","year":"2020","unstructured":"Novella-Navarro M et al (2020) Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis. Arthritis Res Ther 22:1\u20138","journal-title":"Arthritis Res Ther"},{"key":"1844_CR171","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1146\/annurev-med-051113-024537","volume":"66","author":"JJ O\u2019Shea","year":"2015","unstructured":"O\u2019Shea JJ et al (2015) The JAK-STAT pathway: impact on human disease and therapeutic intervention. Annu Rev Med 66:311\u2013328","journal-title":"Annu Rev Med"},{"key":"1844_CR172","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1146\/annurev-immunol-031210-101312","volume":"29","author":"W Ouyang","year":"2011","unstructured":"Ouyang W et al (2011) Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol 29:71\u2013109","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"1844_CR173","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13075-018-1597-9","volume":"20","author":"X Ouyang","year":"2018","unstructured":"Ouyang X et al (2018) Activation of PI3K\/Akt\/mTOR signaling pathway in fibroblast-like synoviocytes contributes to synovial hyperplasia in rheumatoid arthritis. Arthritis Res Ther 20(1):107","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"1844_CR174","first-page":"186","volume":"6","author":"H Pan","year":"2012","unstructured":"Pan H, Wang H, Wang X, Zhu L, Mao L (2012) The inhibitory effect of quercetin on CYP3A4 and CYP2C9 in vitro. Drug Metab Lett 6(3):186\u2013191","journal-title":"Drug Metab Lett"},{"issue":"3","key":"1844_CR175","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3390\/ijms19030716","volume":"19","author":"Y Pan","year":"2018","unstructured":"Pan Y et al (2018) Berberine enhances autophagy to protect against rotenone-induced neurotoxicity in PC12 cells through inhibition of the Akt\/mTOR pathway. Int J Mol Sci 19(3):716","journal-title":"Int J Mol Sci"},{"key":"1844_CR176","first-page":"550","volume":"43","author":"D Pando","year":"2015","unstructured":"Pando D et al (2015) Resveratrol entrapped in casein nanoparticles improves stability and antioxidant activity. Food Hydrocoll 43:550\u2013556","journal-title":"Food Hydrocoll"},{"issue":"3","key":"1844_CR177","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2174\/157488409789375311","volume":"4","author":"A Panossian","year":"2009","unstructured":"Panossian A, Wikman G (2009) Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity. Curr Clin Pharmacol 4(3):198\u2013219","journal-title":"Curr Clin Pharmacol"},{"issue":"3","key":"1844_CR178","first-page":"479","volume":"29","author":"DW Park","year":"2012","unstructured":"Park DW et al (2012) Resveratrol inhibits mTOR signaling by targeting mTORC1 and mTORC2 in human leukemia U937 cells. Int J Mol Med 29(3):479\u2013484","journal-title":"Int J Mol Med"},{"key":"1844_CR179","volume":"11","author":"SH Park","year":"2020","unstructured":"Park SH, Kim JH, Choi JH (2020) AMPK activators as therapeutic agents for rheumatoid arthritis: targeting mTOR signaling. Front Immunol 11:625255","journal-title":"Front Immunol"},{"key":"1844_CR180","first-page":"551","volume":"84","author":"S Park","year":"2020","unstructured":"Park S et al (2020) Kaempferitrin suppresses LPS-induced inflammatory responses in RAW 264.7 macrophages by inhibiting PI3K\/Akt\/mTOR and NF-\u03baB signaling pathways. Int Immunopharmacol 84:551","journal-title":"Int Immunopharmacol"},{"key":"1844_CR181","unstructured":"Chinese Patent CN106743363A (2017) Berberine SLNs for inflammatory arthritis. State Intellectual Property Office of China"},{"key":"1844_CR182","unstructured":"Chinese Patent CN112432169A (2021) Resveratrol nanosuspensions for enhanced bioavailability in rheumatoid arthritis. China National Intellectual Property Administration"},{"key":"1844_CR183","unstructured":"US Patent US20120141520A1 (2012) Nanoparticle formulation of curcumin for autoimmune and inflammatory diseases. U.S. Patent and Trademark Office"},{"key":"1844_CR184","unstructured":"US Patent US20200289781A1 (2020) Quercetin nanoparticle systems for inflammatory joint diseases. U.S. Patent and Trademark Office"},{"key":"1844_CR185","unstructured":"US Patent US20210059644A1 (2021) Dual-drug nanomicelles containing curcumin and methotrexate for rheumatoid arthritis. U.S. Patent and Trademark Office"},{"issue":"2","key":"1844_CR186","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.drudis.2015.01.009","volume":"21","author":"E Patridge","year":"2016","unstructured":"Patridge E, Gareiss P, Kinch MS, Hoyer D (2016) An analysis of FDA-approved drugs: natural products and their derivatives. Drug Discov Today 21(2):204\u2013207","journal-title":"Drug Discov Today"},{"issue":"3","key":"1844_CR187","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1042\/BJ20070540","volume":"405","author":"LR Pearce","year":"2007","unstructured":"Pearce LR et al (2007) Identification of Protor as a novel Rictor-binding component of mTOR complex-2. Biochem J 405(3):513\u2013522","journal-title":"Biochem J"},{"issue":"1","key":"1844_CR188","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/nyas.12756","volume":"1346","author":"A Perl","year":"2015","unstructured":"Perl A (2015) mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging. Ann N Y Acad Sci 1346(1):33\u201344","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"1844_CR189","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrrheum.2015.172","volume":"12","author":"A Perl","year":"2016","unstructured":"Perl A (2016) Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases. Nat Rev Rheumatol 12(3):169\u2013182","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"1844_CR190","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.cell.2009.03.046","volume":"137","author":"TR Peterson","year":"2009","unstructured":"Peterson TR et al (2009) DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell 137(5):873\u2013886","journal-title":"Cell"},{"issue":"2","key":"1844_CR191","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ccr.2006.07.003","volume":"10","author":"TL Phung","year":"2006","unstructured":"Phung TL et al (2006) Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin. Cancer Cell 10(2):159\u2013170","journal-title":"Cancer Cell"},{"issue":"4","key":"1844_CR192","first-page":"955","volume":"35","author":"L Qin","year":"2016","unstructured":"Qin L et al (2016) Tripterygium wilfordii Hook F combined with methotrexate for rheumatoid arthritis: a systematic review and meta-analysis. Clin Rheumatol 35(4):955\u2013964","journal-title":"Clin Rheumatol"},{"key":"1844_CR193","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3389\/fphar.2019.01360","volume":"10","author":"S Qin","year":"2019","unstructured":"Qin S et al (2019) Curcumin attenuates rheumatoid arthritis progression by regulating the PI3K\/Akt\/mTOR signaling pathway. Front Pharmacol 10:1360","journal-title":"Front Pharmacol"},{"key":"1844_CR194","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10354-015-0344-y","volume":"165","author":"H Radner","year":"2015","unstructured":"Radner H, Aletaha D (2015) Anti-TNF therapie in der rheumatoiden arthritisein \u00dcberblick. Wien Med Wochenschr 165:3\u20139","journal-title":"Wien Med Wochenschr"},{"issue":"1","key":"1844_CR195","first-page":"84","volume":"26","author":"HR Rahimi","year":"2020","unstructured":"Rahimi HR et al (2020) A review of curcumin and its derivatives as potent anti-inflammatory and anti-arthritic agents. Curr Pharm des 26(1):84\u201395","journal-title":"Curr Pharm des"},{"issue":"2","key":"1844_CR196","first-page":"112","volume":"21","author":"R Raina","year":"2021","unstructured":"Raina R et al (2021) Luteolin inhibits proliferation, triggers apoptosis and modulates Akt\/mTOR and MAP kinase pathways in HeLa cells. Oncol Lett 21(2):112","journal-title":"Oncol Lett"},{"key":"1844_CR197","volume":"158","author":"P Ramesh","year":"2023","unstructured":"Ramesh P, Das UN (2023) EGCG-loaded hyaluronic acid nanoparticles inhibit inflammatory responses in activated macrophages and prevent joint damage in RA model. Biomed Pharmacother 158:114182","journal-title":"Biomed Pharmacother"},{"key":"1844_CR198","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1002\/fsn3.3308","volume":"6","author":"M Riaz","year":"2023","unstructured":"Riaz M et al (2023) Phytobioactive compounds as therapeutic agents for human diseases: a review. Food Sci Nutr 6:2500\u20132529","journal-title":"Food Sci Nutr"},{"issue":"4","key":"1844_CR199","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.molcel.2013.12.019","volume":"53","author":"DJ Roberts","year":"2014","unstructured":"Roberts DJ et al (2014) Hexokinase-II positively regulates glucose starvation-induced autophagy through TORC1 inhibition. Mol Cell 53(4):521\u2013533","journal-title":"Mol Cell"},{"issue":"3","key":"1844_CR200","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jbspin.2010.02.009","volume":"77","author":"A Ruyssen-Witrand","year":"2010","unstructured":"Ruyssen-Witrand A et al (2010) Infections induced by low-dose corticosteroids in rheumatoid arthritis: a systematic literature review. Jt Bone Spine 77(3):246\u2013251","journal-title":"Jt Bone Spine"},{"issue":"1","key":"1844_CR201","first-page":"23","volume":"27","author":"HW Ryu","year":"2017","unstructured":"Ryu HW et al (2017) Luteolin and luteolin-7-O-glucoside inhibit IL-6 production in LPS-stimulated RAW2647 cells and their structure\u2013activity relationships. Bioorg Med Chem Lett 27(1):23\u201327","journal-title":"Bioorg Med Chem Lett"},{"issue":"45","key":"1844_CR202","doi-asserted-by":"publisher","first-page":"11818","DOI":"10.1073\/pnas.1716173114","volume":"114","author":"DM Sabatini","year":"2017","unstructured":"Sabatini DM (2017) Twenty-five years of mTOR: Uncovering the link from nutrients to growth. Proc Natl Acad Sci USA 114(45):11818\u201311825","journal-title":"Proc Natl Acad Sci USA"},{"key":"1844_CR203","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fcell.2018.00122","volume":"6","author":"RJ Salmond","year":"2018","unstructured":"Salmond RJ (2018) mTOR regulation of glycolytic metabolism in T cells. Front Cell Dev Biol 6:122","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"1844_CR204","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.molcel.2007.03.003","volume":"25","author":"Y Sancak","year":"2007","unstructured":"Sancak Y et al (2007) PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell 25(6):903\u2013915","journal-title":"Mol Cell"},{"issue":"5","key":"1844_CR205","first-page":"FD01","volume":"9","author":"D Satyanarayanasetty","year":"2015","unstructured":"Satyanarayanasetty D et al (2015) Multiple adverse effects of systemic corticosteroids: a case report. J Clin Diagn Res 9(5):FD01","journal-title":"J Clin Diagn Res"},{"issue":"6","key":"1844_CR206","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton RA (2017) Sabatini DM (2027) mTOR signaling in growth, metabolism, and disease. Cell 168(6):960\u2013976","journal-title":"Cell"},{"issue":"11","key":"1844_CR207","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrrheum.2012.153","volume":"8","author":"G Schett","year":"2012","unstructured":"Schett G, Gravallese E (2012) Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment. Nat Rev Rheumatol 8(11):656\u2013664","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"1844_CR208","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","volume":"16","author":"E Schrezenmeier","year":"2020","unstructured":"Schrezenmeier E, D\u00f6rner T (2020) Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol 16(3):155\u2013166","journal-title":"Nat Rev Rheumatol"},{"issue":"14","key":"1844_CR209","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1055\/s-0028-1088314","volume":"74","author":"G Seelinger","year":"2008","unstructured":"Seelinger G, Merfort I, Schempp CM (2008) Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta Med 74(14):1667\u20131677","journal-title":"Planta Med"},{"issue":"6","key":"1844_CR210","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1080\/14397595.2017.1280118","volume":"27","author":"M Seki","year":"2017","unstructured":"Seki M et al (2017) Functional analysis of choline transporters in rheumatoid arthritis synovial fibroblasts. Mod Rheumatol 27(6):995\u20131003","journal-title":"Mod Rheumatol"},{"issue":"9","key":"1844_CR211","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1002\/art.30439","volume":"63","author":"S Serrat\u00ec","year":"2011","unstructured":"Serrat\u00ec S et al (2011) Reduction of in vitro invasion and in vivo cartilage degradation in a SCID mouse model by loss of function of the fibrinolytic system of rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 63(9):2584\u20132594","journal-title":"Arthritis Rheum"},{"key":"1844_CR212","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3389\/fimmu.2020.00946","volume":"11","author":"A Shaito","year":"2020","unstructured":"Shaito A et al (2020a) Resveratrol as a potential therapeutic candidate for rheumatoid arthritis. Front Immunol 11:946","journal-title":"Front Immunol"},{"key":"1844_CR213","volume":"7","author":"A Shaito","year":"2020","unstructured":"Shaito A et al (2020b) Resveratrol: a potential complementary treatment for rheumatoid arthritis. Front Nutr 7:579844","journal-title":"Front Nutr"},{"issue":"5","key":"1844_CR214","first-page":"677","volume":"76","author":"M Shakibaei","year":"2008","unstructured":"Shakibaei M et al (2008) Resveratrol suppresses interleukin-1\u03b2-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis. Biochem Pharmacol 76(5):677\u2013687","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"1844_CR215","first-page":"1012","volume":"115","author":"M Shakibaei","year":"2014","unstructured":"Shakibaei M et al (2014) Curcumin enhances the efficacy of chemotherapeutic agents in cancer cells by targeting the PI3K\/Akt\/mTOR pathway. J Cell Biochem 115(5):1012\u20131021","journal-title":"J Cell Biochem"},{"issue":"1","key":"1844_CR216","first-page":"105","volume":"13","author":"RA Sharma","year":"2004","unstructured":"Sharma RA, Steward WP, Gescher AJ (2004) Pharmacokinetics and pharmacodynamics of curcumin in humans. Cancer Epidemiol Biomarkers Prev 13(1):105\u2013111","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"1844_CR217","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s13205-018-1423-8","volume":"8","author":"BR Sharma","year":"2018","unstructured":"Sharma BR et al (2018) Microbial maceration: a sustainable approach for phytochemical extraction. 3 Biotech 8(9):401","journal-title":"3 Biotech"},{"issue":"3","key":"1844_CR218","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10067-019-04812-x","volume":"39","author":"P Shen","year":"2020","unstructured":"Shen P et al (2020) Quercetin inhibits inflammation and promotes apoptosis in rheumatoid arthritis fibroblast-like synoviocytes by downregulating the PI3K\/Akt\/mTOR pathway. Clin Rheumatol 39(3):703\u2013771","journal-title":"Clin Rheumatol"},{"issue":"6","key":"1844_CR219","first-page":"1687","volume":"35","author":"R Shi","year":"2015","unstructured":"Shi R et al (2015) Luteolin suppresses tumor proliferation through regulation of IGF-1R\/Akt\/mTOR signaling pathway. Int J Mol Med 35(6):1687\u20131693","journal-title":"Int J Mol Med"},{"issue":"1","key":"1844_CR220","first-page":"1554","volume":"29","author":"J Shi","year":"2022","unstructured":"Shi J et al (2022) Nanoparticle-based delivery of artemisinin and its derivatives: opportunities and challenges in rheumatoid arthritis therapy. Drug Deliv 29(1):1554\u20131565","journal-title":"Drug Deliv"},{"issue":"5","key":"1844_CR221","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1517\/13543776.8.5.531","volume":"8","author":"MG Shire","year":"1998","unstructured":"Shire MG, Muller GW (1998) TNF-\u03b1 inhibitors and rheumatoid arthritis. Expert Opin Ther Pat 8(5):531\u2013544","journal-title":"Expert Opin Ther Pat"},{"issue":"6","key":"1844_CR222","first-page":"884","volume":"66","author":"IA Siddiqui","year":"2014","unstructured":"Siddiqui IA, Adhami VM, Ahmad N, Mukhtar H (2014) Nanochemoprevention: sustained release of bioactive food components for cancer prevention. Nutr Cancer 66(6):884\u2013890","journal-title":"Nutr Cancer"},{"issue":"5","key":"1844_CR223","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ni.2556","volume":"14","author":"LV Sinclair","year":"2013","unstructured":"Sinclair LV et al (2013) Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat Immunol 14(5):500\u2013508","journal-title":"Nat Immunol"},{"issue":"3","key":"1844_CR224","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1186\/ar3337","volume":"13","author":"R Singh","year":"2011","unstructured":"Singh R et al (2011) Epigallocatechin-3-gallate ameliorates rheumatoid arthritis by inhibiting mTOR and NF-\u03baB pathways. Arthritis Res Ther 13(3):R75","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"1844_CR225","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.39480","volume":"68","author":"JA Singh","year":"2016","unstructured":"Singh JA et al (2016a) 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 68(1):1\u201326","journal-title":"Arthritis Rheumatol"},{"key":"1844_CR226","first-page":"489","volume":"7","author":"Y Singh","year":"2016","unstructured":"Singh Y et al (2016b) Molecular evidence of synergism between natural compounds and DMARDs in arthritis. Front Pharmacol 7:489","journal-title":"Front Pharmacol"},{"issue":"12","key":"1844_CR227","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1002\/ptr.6508","volume":"33","author":"VK Singh","year":"2019","unstructured":"Singh VK et al (2019) Phytochemicals based chemopreventive and chemotherapeutic strategies and modern technologies to overcome limitations for better clinical applications. Phytother Res 33(12):3064\u20133089","journal-title":"Phytother Res"},{"key":"1844_CR228","volume":"77","author":"S Singh","year":"2020","unstructured":"Singh S et al (2020) Phytochemicals as novel modulators of mTOR signaling in autoimmune diseases: therapeutic implications in rheumatoid arthritis. Phytomed 77:153248","journal-title":"Phytomed"},{"key":"1844_CR229","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ijbiomac.2020.12.004","volume":"168","author":"D Singh","year":"2021","unstructured":"Singh D et al (2021a) Hyaluronic acid and folic acid decorated polymeric nanocarriers for targeted delivery in rheumatoid arthritis. Int J Biol Macromol 168:755\u2013768","journal-title":"Int J Biol Macromol"},{"issue":"5","key":"1844_CR230","first-page":"703","volume":"47","author":"D Singh","year":"2021","unstructured":"Singh D et al (2021b) Quercetin-loaded phytosomes for enhanced bioavailability in rheumatoid arthritis: Design and in vivo evaluation. Drug Dev Ind Pharm 47(5):703\u2013712","journal-title":"Drug Dev Ind Pharm"},{"issue":"10055","key":"1844_CR231","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388(10055):2023\u20132038","journal-title":"Lancet"},{"key":"1844_CR232","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","volume":"4","author":"JS Smolen","year":"2018","unstructured":"Smolen JS et al (2018) Rheumatoid arthritis. Nat Rev Dis Primers 4:18001","journal-title":"Nat Rev Dis Primers"},{"key":"1844_CR233","first-page":"8852478","volume":"2023","author":"C Song","year":"2023","unstructured":"Song C et al (2023) Resveratrol protects against RA-associated interstitial lung disease by restoring autophagic flux. Mediators Inflamm 2023:8852478","journal-title":"Mediators Inflamm"},{"issue":"6","key":"1844_CR234","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3109\/10799893.2015.1030412","volume":"35","author":"Y Sun","year":"2015","unstructured":"Sun Y, Liu WZ, Liu T, Feng X, Yang N, Zhou HF (2015) Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Res 35(6):600\u2013604","journal-title":"J Recept Signal Transduct Res"},{"key":"1844_CR235","volume":"84","author":"H Sun","year":"2021","unstructured":"Sun H et al (2021a) Kaempferitrin attenuates collagen-induced arthritis in rats by modulating mTOR-mediated autophagy and inflammation. Phytomed 84:153507","journal-title":"Phytomed"},{"key":"1844_CR236","volume":"12","author":"Y Sun","year":"2021","unstructured":"Sun Y et al (2021b) mTORC1 inhibitor suppresses inflammation in collagen-induced arthritis by regulating M1\/M2 macrophage polarization. Front Immunol 12:629608","journal-title":"Front Immunol"},{"key":"1844_CR237","first-page":"658","volume":"4","author":"NR Sundaresan","year":"1813","unstructured":"Sundaresan NR et al (1813) (2011) SIRT1 modulates mTOR signaling and the role of AMPK in cell survival. Biochim Biophys Acta 4:658\u2013668","journal-title":"Biochim Biophys Acta"},{"key":"1844_CR238","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-017-1283-3","volume":"19","author":"S Takahashi","year":"2017","unstructured":"Takahashi S et al (2017) Glutaminase 1 plays a key role in the cell growth of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther 19:1\u201310","journal-title":"Arthritis Res Ther"},{"key":"1844_CR239","volume":"267","author":"W Tang","year":"2021","unstructured":"Tang W et al (2021a) The protective effect of pristimerin on rheumatoid arthritis: modulation of NF-\u03baB and mTOR-mediated autophagy. J Ethnopharmacol 267:113513","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"1844_CR240","first-page":"215","volume":"54","author":"Y Tang","year":"2021","unstructured":"Tang Y, Liu W, Wang Y, Zhou J, Huang M (2021b) Gambogic acid restores Treg\/Th17 balance and reduces pro-inflammatory cytokines in CIA mice through mTOR inhibition. Autoimmunity 54(4):215\u2013225","journal-title":"Autoimmunity"},{"issue":"14","key":"1844_CR241","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1111\/jcmm.17418","volume":"26","author":"H Tang","year":"2022","unstructured":"Tang H et al (2022) Quercetin Promotes Autophagy and Reduces Inflammation via mTOR Suppression in Rheumatoid Arthritis Synoviocytes. J Cell Mol Med 26(14):3970\u20133981","journal-title":"J Cell Mol Med"},{"issue":"10","key":"1844_CR242","first-page":"2160","volume":"28","author":"X Tao","year":"2001","unstructured":"Tao X, Cush JJ, Garret M, Lipsky PE (2001) A phase I study of ethyl acetate extract of Tripterygium wilfordii Hook F in rheumatoid arthritis. J Rheumatol 28(10):2160\u20132167","journal-title":"J Rheumatol"},{"issue":"15","key":"1844_CR243","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/S0960-9822(03)00506-2","volume":"13","author":"AR Tee","year":"2003","unstructured":"Tee AR et al (2003) Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr Biol 13(15):1259\u20131268","journal-title":"Curr Biol"},{"issue":"6","key":"1844_CR244","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.3390\/ijms19061578","volume":"19","author":"NE Thomford","year":"2018","unstructured":"Thomford NE et al (2018) Natural products for drug discovery in the 21st century: innovations for novel drug discovery. Int J Mol Sci 19(6):1578","journal-title":"Int J Mol Sci"},{"issue":"10","key":"1844_CR245","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.bcp.2012.07.018","volume":"84","author":"M Tillhon","year":"2012","unstructured":"Tillhon M, Guam\u00e1n Ortiz LM, Lombardi P, Scovassi AI (2012) Berberine: new perspectives for old remedies. Biochem Pharmacol 84(10):1260\u20131267","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"1844_CR246","first-page":"1016","volume":"72","author":"N Turner","year":"2020","unstructured":"Turner N et al (2020) Berberine and its derivatives: a modern plant alkaloid with a wide spectrum of pharmacological activities. Pharmacol Rev 72(4):1016\u20131051","journal-title":"Pharmacol Rev"},{"issue":"6","key":"1844_CR247","first-page":"1017","volume":"27","author":"K Visser","year":"2009","unstructured":"Visser K, van der Heijde D (2009) Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature. Clin Exp Rheumatol 27(6):1017\u20131025","journal-title":"Clin Exp Rheumatol"},{"key":"1844_CR248","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1749-6632.2010.05842.x","volume":"1215","author":"T Walle","year":"2011","unstructured":"Walle T (2011) Bioavailability of resveratrol. Ann N Y Acad Sci 1215:9\u201315","journal-title":"Ann N Y Acad Sci"},{"key":"1844_CR249","volume":"100","author":"Y Wang","year":"2022","unstructured":"Wang Y (2022) Resveratrol regulates macrophage polarization and ameliorates arthritis via inhibiting the mTOR signaling. Int Immunopharmacol 100:108106","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"1844_CR250","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jep.2012.12.013","volume":"146","author":"Q Wang","year":"2013","unstructured":"Wang Q et al (2013) Naturally derived anti-inflammatory compounds from Chinese medicinal plants. J Ethnopharmacol 146(1):9\u201339","journal-title":"J Ethnopharmacol"},{"key":"1844_CR251","first-page":"175","volume":"45","author":"Y Wang","year":"2017","unstructured":"Wang Y et al (2017) Gambogic acid attenuates inflammation by inhibiting the PI3K\/Akt\/mTOR pathway and enhances autophagy in fibroblast-like synoviocytes of RA. Int Immunopharmacol 45:175\u2013183","journal-title":"Int Immunopharmacol"},{"key":"1844_CR252","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.2147\/IJN.S185806","volume":"13","author":"X Wang","year":"2018","unstructured":"Wang X et al (2018) Enhanced delivery of artemisinin using a lipid-based nanoparticle system for treatment of inflammation. Int J Nanomed 13:8579\u20138590","journal-title":"Int J Nanomed"},{"key":"1844_CR253","doi-asserted-by":"crossref","first-page":"108722","DOI":"10.1016\/j.cbi.2019.06.035","volume":"310","author":"H Wang","year":"2019","unstructured":"Wang H et al (2019) (2019) Toxicological effects of celastrol: insights into its mechanisms and strategies for safer application. Chem Biol Interact 310:108722","journal-title":"Chem Biol Interact"},{"issue":"8","key":"1844_CR254","first-page":"13043","volume":"120","author":"C Wang","year":"2019","unstructured":"Wang C et al (2019a) Astragalus polysaccharide suppresses rheumatoid arthritis inflammation through inhibition of NF-\u03baB and mTOR signaling pathways. J Cell Biochem 120(8):13043\u201313052","journal-title":"J Cell Biochem"},{"issue":"9","key":"1844_CR255","first-page":"1016","volume":"47","author":"J Wang","year":"2019","unstructured":"Wang J et al (2019b) Pharmacokinetics, tissue distribution, and excretion of pristimerin in rats: implications for its low bioavailability. Drug Metab Dispos 47(9):1016\u20131023","journal-title":"Drug Metab Dispos"},{"key":"1844_CR256","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.3389\/fphar.2019.01288","volume":"10","author":"Q Wang","year":"2019","unstructured":"Wang Q et al (2019c) Celastrol inhibits rheumatoid arthritis through the PI3K\/Akt\/mTOR signaling pathway. Front Pharmacol 10:1288","journal-title":"Front Pharmacol"},{"issue":"1","key":"1844_CR257","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13075-021-02715-4","volume":"22","author":"J Wang","year":"2020","unstructured":"Wang J, Tan X, Peng J, Guo Y (2020a) Curcumin inhibits the mTOR pathway and enhances autophagy in rheumatoid arthritis synovial fibroblasts. Arthritis Res Ther 22(1):17","journal-title":"Arthritis Res Ther"},{"key":"1844_CR258","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106298","volume":"82","author":"L Wang","year":"2020","unstructured":"Wang L et al (2020b) Artemisinin inhibits the migration and invasion of fibroblast-like synoviocytes from rheumatoid arthritis patients through inhibition of mTOR pathway. Int Immunopharmacol 82:106298","journal-title":"Int Immunopharmacol"},{"key":"1844_CR259","volume":"12","author":"C Wang","year":"2021","unstructured":"Wang C et al (2021a) Celastrol attenuates inflammation and promotes regulatory T cell differentiation in RA through mTOR inhibition. Front Immunol 12:631700","journal-title":"Front Immunol"},{"key":"1844_CR260","volume":"12","author":"Q Wang","year":"2021","unstructured":"Wang Q et al (2021b) Celastrol inhibits rheumatoid arthritis inflammation via targeting mTOR signaling pathway. Front Pharmacol 12:631384","journal-title":"Front Pharmacol"},{"key":"1844_CR261","volume":"225","author":"W Wang","year":"2021","unstructured":"Wang W et al (2021c) Resveratrol inhibits Th17 cell differentiation by upregulating SIRT1 and downregulating mTOR signaling in rheumatoid arthritis. Clin Immunol 225:108669","journal-title":"Clin Immunol"},{"issue":"6","key":"1844_CR262","first-page":"1573","volume":"29","author":"Y Wang","year":"2021","unstructured":"Wang Y et al (2021d) Luteolin ameliorates collagen-induced arthritis in rats by inhibiting mTOR and NF-\u03baB signaling pathways. Inflammopharmacol 29(6):1573\u20131585","journal-title":"Inflammopharmacol"},{"key":"1844_CR263","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Chen X, Du Z, Yang G, Liu H (2021e) Gambogic acid modulates Th17\/Treg balance and ameliorates experimental arthritis by inhibiting the mTOR pathway. Front Immunol 12:643179","journal-title":"Front Immunol"},{"issue":"2","key":"1844_CR264","first-page":"361","volume":"12","author":"W Wang","year":"2022","unstructured":"Wang W et al (2022) Targeted delivery of quercetin via pH-sensitive nanoparticles for effective treatment of rheumatoid arthritis. Drug Deliv Transl Res 12(2):361\u2013371","journal-title":"Drug Deliv Transl Res"},{"issue":"12","key":"1844_CR265","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.3390\/molecules28124846","volume":"28","author":"J Wang","year":"2023","unstructured":"Wang J et al (2023a) Resveratrol inhibits synovial angiogenesis in RA through the SIRT1\/HIF-1\u03b1 pathway. Molecules 28(12):4846","journal-title":"Molecules"},{"key":"1844_CR266","first-page":"1145679","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y et al (2023b) EGCG suppresses rheumatoid arthritis via modulation of mTOR-mediated autophagy and apoptosis pathways. Front Pharmacol 14:1145679","journal-title":"Front Pharmacol"},{"issue":"4","key":"1844_CR267","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.immuni.2008.08.012","volume":"29","author":"T Weichhart","year":"2008","unstructured":"Weichhart T et al (2008) The TSC-mTOR signaling pathway regulates the innate inflammatory response. Immunity 29(4):565\u2013577","journal-title":"Immunity"},{"key":"1844_CR268","unstructured":"WIPO. WO2018211745A1 (2018) Liposomal berberine-phospholipid complexes for autoimmune disease therapy"},{"key":"1844_CR269","unstructured":"WIPO. WO2019048223A1 (2019) Nanoparticle composition for resveratrol delivery in autoimmune diseases"},{"issue":"2","key":"1844_CR270","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.cmet.2017.07.001","volume":"26","author":"RL Wolfson","year":"2017","unstructured":"Wolfson RL, Sabatini DM (2017) The dawn of the age of amino acid sensors for the mTORC1 pathway. Cell Metab 26(2):301\u2013309","journal-title":"Cell Metab"},{"issue":"6268","key":"1844_CR271","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1126\/science.aab2674","volume":"351","author":"RL Wolfson","year":"2016","unstructured":"Wolfson RL et al (2016) Sestrin2 is a leucine sensor for the mTORC1 pathway. Science 351(6268):43\u201348","journal-title":"Science"},{"key":"1844_CR272","unstructured":"World Intellectual Property Organization (WIPO) (2010) WO2010133057A2. Liposomal curcumin for controlled release in inflammatory disorders"},{"key":"1844_CR273","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.intimp.2018.10.036","volume":"65","author":"Y Wu","year":"2018","unstructured":"Wu Y et al (2018) Pristimerin Attenuates Rheumatoid Arthritis by Promoting Autophagy via Inhibition of the PI3K\/Akt\/mTOR Pathway. Int Immunopharmacol 65:458\u2013466","journal-title":"Int Immunopharmacol"},{"key":"1844_CR274","volume":"90","author":"M Wu","year":"2021","unstructured":"Wu M et al (2021) Celastrol improves immune regulation in RA by promoting Treg cell differentiation and suppressing Th17 cells. Int Immunopharmacol 90:107148","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"1844_CR275","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.cell.2017.09.046","volume":"171","author":"GA Wyant","year":"2017","unstructured":"Wyant GA et al (2017) mTORC1 activator SLC38A9 is required to efflux essential amino acids from lysosomes and use protein as a nutrient. Cell 171(3):642\u2013654","journal-title":"Cell"},{"issue":"2","key":"1844_CR276","first-page":"1071","volume":"20","author":"Y Xiang","year":"2019","unstructured":"Xiang Y et al (2019) Methotrexate inhibits the PI3K\/Akt\/mTOR signaling pathway in rheumatoid arthritis fibroblast-like synoviocytes. Mol Med Rep 20(2):1071\u20131078","journal-title":"Mol Med Rep"},{"key":"1844_CR277","volume":"13","author":"J Xiao","year":"2022","unstructured":"Xiao J et al (2022a) Astragaloside IV alleviates rheumatoid arthritis by regulating autophagy via mTOR inhibition and AMPK activation. Front Pharmacol 13:836246","journal-title":"Front Pharmacol"},{"key":"1844_CR278","volume":"13","author":"Y Xiao","year":"2022","unstructured":"Xiao Y et al (2022b) Luteolin regulates Th17\/Treg cell balance and suppresses rheumatoid arthritis progression by targeting PI3K\/AKT\/mTOR signaling. Front Immunol 13:847123","journal-title":"Front Immunol"},{"issue":"8","key":"1844_CR279","first-page":"1101","volume":"22","author":"D Xu","year":"2017","unstructured":"Xu D et al (2017) Polymeric nanoparticles enhance oral bioavailability of astragaloside IV: in vitro and in vivo studies. Pharm Dev Technol 22(8):1101\u20131107","journal-title":"Pharm Dev Technol"},{"issue":"1","key":"1844_CR280","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1142\/S0192415X13500018","volume":"46","author":"J Xu","year":"2018","unstructured":"Xu J et al (2018) Berberine modulates Th17 and Treg cell balance in colitis via the mTOR pathway. Am J Chin Med 46(1):1\u201313","journal-title":"Am J Chin Med"},{"key":"1844_CR281","first-page":"94","volume":"70","author":"H Xu","year":"2019","unstructured":"Xu H et al (2019) AMPK activation inhibits the inflammatory response via mTOR signaling in rheumatoid arthritis synovial fibroblasts. Int Immunopharmacol 70:94\u2013102","journal-title":"Int Immunopharmacol"},{"key":"1844_CR282","volume":"106","author":"J Xue","year":"2022","unstructured":"Xue J et al (2022) Quercetin alleviates experimental arthritis by regulating the PI3K\/Akt\/mTOR axis and balancing Th17\/Treg differentiation. Int Immunopharmacol 106:108590","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"1844_CR283","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1208\/s12248-015-9811-z","volume":"17","author":"MM Yallapu","year":"2012","unstructured":"Yallapu MM, Nagesh PKB, Jaggi M, Chauhan SC (2012) Therapeutic applications of curcumin nanoformulations. AAPS J 17(6):1341\u20131356","journal-title":"AAPS J"},{"issue":"1","key":"1844_CR284","first-page":"292","volume":"65","author":"MM Yallapu","year":"2013","unstructured":"Yallapu MM et al (2013) Curcumin-loaded PLGA nanoparticles for enhanced therapeutic efficacy in rheumatoid arthritis. Arthritis Rheum 65(1):292\u2013302","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1844_CR285","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.phrs.2011.03.001","volume":"64","author":"CS Yang","year":"2011","unstructured":"Yang CS et al (2011) Cancer prevention by tea: Evidence from laboratory studies. Pharmacol Res 64(2):113\u2013122","journal-title":"Pharmacol Res"},{"issue":"7448","key":"1844_CR286","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature12122","volume":"497","author":"H Yang","year":"2013","unstructured":"Yang H et al (2013) mTOR kinase structure, mechanism and regulation. Nat 497(7448):217\u2013223","journal-title":"Nat"},{"issue":"6","key":"1844_CR287","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.celrep.2015.07.016","volume":"12","author":"G Yang","year":"2015","unstructured":"Yang G et al (2015) A positive feedback loop between Akt and mTORC2 via SIN1 phosphorylation. Cell Rep 12(6):937\u2013943","journal-title":"Cell Rep"},{"key":"1844_CR288","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3389\/fimmu.2020.00949","volume":"11","author":"M Yang","year":"2020","unstructured":"Yang M, Sun J, Lu L, Wang S (2020) mTOR signaling in autoimmune diseases: a comprehensive review. Front Immunol 11:949","journal-title":"Front Immunol"},{"key":"1844_CR289","doi-asserted-by":"crossref","first-page":"108539","DOI":"10.1016\/j.intimp.2022.108539","volume":"105","author":"C Yang","year":"2022","unstructured":"Yang C et al (2022) Epigallocatechin-3-gallate promotes autophagy and enhances anti-inflammatory effects of dexamethasone in RAW264.7 macrophages via the mTOR pathway. Int Immunopharmacol 105:108539","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"1844_CR290","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/cells7100161","volume":"7","author":"HY Yap","year":"2018","unstructured":"Yap HY et al (2018) Pathogenic role of immune cells in rheumatoid arthritis: implications in clinical treatment and biomarker development. Cells 7(10):161","journal-title":"Cells"},{"key":"1844_CR291","volume":"13","author":"Y Yin","year":"2022","unstructured":"Yin Y, Chen Y, Zhang X (2022) Targeting mTOR in Autoimmune Diseases: Challenges and Perspectives. Front Pharmacol 13:821108","journal-title":"Front Pharmacol"},{"issue":"1","key":"1844_CR292","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.intimp.2016.02.032","volume":"26","author":"D Yu","year":"2016","unstructured":"Yu D et al (2016) Astragaloside IV prevents acute kidney injury through anti-oxidant and anti-apoptotic effects via modulation of the Akt\/mTOR\/p70S6K signaling pathway. Int Immunopharmacol 26(1):129\u2013138","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"1844_CR293","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00726-017-2520-4","volume":"50","author":"Z Yu","year":"2018","unstructured":"Yu Z et al (2018) Fibroblast-like synoviocyte migration is enhanced by IL-17-mediated overexpression of L-type amino acid transporter 1 (LAT1) via the mTOR\/4E-BP1 pathway. J Amino Acids 50(2):331\u2013340","journal-title":"J Amino Acids"},{"key":"1844_CR294","first-page":"10","volume":"160","author":"Q Yuan","year":"2017","unstructured":"Yuan Q et al (2017) Quercetin-loaded PLGA nanoparticles suppress inflammation in collagen-induced arthritis mice. Colloids Surf B Biointerfaces 160:10\u201317","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1844_CR295","first-page":"2020327","volume":"2018","author":"Q Yuan","year":"2018","unstructured":"Yuan Q et al (2018) Quercetin alleviates collagen-induced arthritis by inhibiting synovial fibroblast proliferation and inflammatory cytokine production via the PI3K\/Akt\/mTOR pathway. Mediators Inflamm 2018:2020327","journal-title":"Mediators Inflamm"},{"issue":"13","key":"1844_CR296","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1039\/D1BM00429H","volume":"9","author":"X Yuan","year":"2021","unstructured":"Yuan X et al (2021a) mTOR-targeting and synovial-targeted artemisinin-loaded nanoparticles for treating rheumatoid arthritis. Biomater Sci 9(13):4728\u20134740","journal-title":"Biomater Sci"},{"issue":"17","key":"1844_CR297","first-page":"19906","volume":"13","author":"Z Yuan","year":"2021","unstructured":"Yuan Z et al (2021b) Dual-sensitive nanocarrier for site-specific delivery of celastrol in RA therapy: integrating pH- and ROS-responsive release. ACS Appl Mater Interfaces 13(17):19906\u201319917","journal-title":"ACS Appl Mater Interfaces"},{"issue":"4","key":"1844_CR298","first-page":"804","volume":"123","author":"Z Zakeri","year":"2022","unstructured":"Zakeri Z et al (2022) The effect of nano-curcumin on inflammatory markers and clinical symptoms in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled clinical trial. J Cell Biochem 123(4):804\u2013813","journal-title":"J Cell Biochem"},{"issue":"1","key":"1844_CR299","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/jcp.25913","volume":"233","author":"Q Zeng","year":"2018","unstructured":"Zeng Q et al (2018) Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1\/2 signaling in normal and neoplastic B-lymphoid cells. J Cell Physiol 233(1):516\u2013529","journal-title":"J Cell Physiol"},{"issue":"5","key":"1844_CR300","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/sj.clpt.6100400","volume":"83","author":"L Zhang","year":"2008","unstructured":"Zhang L et al (2008) Nanoparticles in medicine: Therapeutic applications and developments. Clin Pharmacol Ther 83(5):761\u2013769","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"1844_CR301","first-page":"1045","volume":"108","author":"WJ Zhang","year":"2012","unstructured":"Zhang WJ, Hufnagl P, Binder BR, Wojta J (2012) Anti-inflammatory activity of astragaloside IV is mediated through inhibition of NF-\u03baB and MAPK signaling pathways in human endothelial cells. Thromb Haemost 108(5):1045\u20131053","journal-title":"Thromb Haemost"},{"issue":"28","key":"1844_CR302","first-page":"6929","volume":"62","author":"L Zhang","year":"2014","unstructured":"Zhang L et al (2014a) Stability, bioavailability, and anti-inflammatory effects of epigallocatechin gallate (EGCG): a review. J Agric Food Chem 62(28):6929\u20136936","journal-title":"J Agric Food Chem"},{"issue":"2","key":"1844_CR303","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.intimp.2014.05.030","volume":"21","author":"Y Zhang","year":"2014","unstructured":"Zhang Y et al (2014b) Anti-arthritic activity of luteolin in Freund\u2019s complete adjuvant-induced arthritis in rats by suppressing P2X4 pathway. Int Immunopharmacol 21(2):456\u2013463","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"1844_CR304","first-page":"10","volume":"13","author":"Y Zhang","year":"2015","unstructured":"Zhang Y et al (2015) Interactions between traditional Chinese medicines and Western drugs: evidence and potential mechanisms. Chin J Nat Med 13(1):10\u201320","journal-title":"Chin J Nat Med"},{"issue":"1","key":"1844_CR305","first-page":"99","volume":"19","author":"L Zhang","year":"2016","unstructured":"Zhang L et al (2016) Protective effect of Astragalus membranaceus extract on CIA mice by regulation of mTORC1-HIF-1\u03b1 signaling pathway. BMC Complement Altern Med 19(1):99","journal-title":"BMC Complement Altern Med"},{"key":"1844_CR306","first-page":"120","volume":"30","author":"Y Zhang","year":"2017","unstructured":"Zhang Y et al (2017) Sinomenine synergizes with leflunomide to inhibit arthritis progression by targeting the PI3K\/mTOR pathway. Phytomedicine 30:120\u2013127","journal-title":"Phytomedicine"},{"key":"1844_CR307","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2018.09.028","volume":"65","author":"W Zhang","year":"2018","unstructured":"Zhang W et al (2018) Astragaloside IV regulates Th17\/Treg balance via inhibition of mTOR signaling pathway in collagen-induced arthritis. Int Immunopharmacology 65:1\u20138","journal-title":"Int Immunopharmacology"},{"issue":"1","key":"1844_CR308","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12906-019-2507-7","volume":"19","author":"L Zhang","year":"2019","unstructured":"Zhang L et al (2019a) Protective effect of Astragalus membranaceus extract on CIA mice by regulation of mTORC1-HIF-1\u03b1 signaling pathway. BMC Complement Altern Med 19(1):99","journal-title":"BMC Complement Altern Med"},{"issue":"4","key":"1844_CR309","first-page":"687","volume":"45","author":"Q Zhang","year":"2019","unstructured":"Zhang Q et al (2019b) Quercetin-loaded chitosan nanoparticles attenuate inflammation in collagen-induced arthritis rats. Drug Dev Ind Pharm 45(4):687\u2013694","journal-title":"Drug Dev Ind Pharm"},{"key":"1844_CR310","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.3389\/fphar.2019.01285","volume":"10","author":"X Zhang","year":"2019","unstructured":"Zhang X et al (2019c) Celastrol attenuates inflammation and joint destruction by modulating the mTOR pathway in rheumatoid arthritis. Front Pharmacol 10:1285","journal-title":"Front Pharmacol"},{"issue":"2","key":"1844_CR311","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.bbrc.2020.02.093","volume":"525","author":"Q Zhang","year":"2020","unstructured":"Zhang Q et al (2020) Curcumin inhibits RANKL-induced osteoclastogenesis via suppressing the Akt\/mTOR\/NFATc1 pathway in RAW264.7 cells. Biochem Biophys Res Commun 525(2):366\u2013372","journal-title":"Biochem Biophys Res Commun"},{"key":"1844_CR312","volume":"882","author":"J Zhang","year":"2020","unstructured":"Zhang J, Sun X, Wang Y, Zhang S, Liu Y (2020a) Gambogic acid induces apoptosis and suppresses cell migration in RA-FLS through targeting Akt\/mTOR pathway. Eur J Pharmacol 882:173248","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1844_CR313","first-page":"536","volume":"27","author":"L Zhang","year":"2020","unstructured":"Zhang L et al (2020b) Gambogic acid-loaded nanoparticles attenuate experimental arthritis via dual inhibition of inflammatory and oxidative stress pathways. Drug Deliv 27(1):536\u2013545","journal-title":"Drug Deliv"},{"key":"1844_CR314","volume":"84","author":"T Zhang","year":"2020","unstructured":"Zhang T et al (2020c) Celastrol regulates autophagy by targeting mTOR signaling in fibroblast-like synoviocytes of rheumatoid arthritis. Int Immunopharmacol 84:106555","journal-title":"Int Immunopharmacol"},{"key":"1844_CR315","volume":"11","author":"W Zhang","year":"2020","unstructured":"Zhang W et al (2020d) Quercetin modulates inflammation and oxidative stress in collagen-induced arthritis by targeting SIRT1 and mTOR signaling. Front Pharmacol 11:587434","journal-title":"Front Pharmacol"},{"issue":"5","key":"1844_CR316","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3892\/ijmm.2020.4516","volume":"45","author":"Y Zhang","year":"2020","unstructured":"Zhang Y et al (2020e) Astragalus polysaccharide suppresses inflammation and promotes autophagy in fibroblast-like synoviocytes in rheumatoid arthritis by targeting the TLR4-NF-\u03baB signaling pathway. Int J Mol Med 45(5):1349\u20131357","journal-title":"Int J Mol Med"},{"key":"1844_CR317","volume":"76","author":"Y Zhang","year":"2020","unstructured":"Zhang Y et al (2020f) Pristimerin attenuates collagen-induced arthritis in mice by inhibiting the PI3K\/Akt\/mTOR signaling pathway. Phytomedicine 76:153257","journal-title":"Phytomedicine"},{"issue":"3","key":"1844_CR318","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12013-020-00928-z","volume":"78","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wang L, Sun X, Yang G (2020g) Gambogic acid induces apoptosis and cell cycle arrest in synoviocytes of RA rats by targeting PI3K\/Akt\/mTOR pathway. Cell Biochem Biophys 78(3):337\u2013345","journal-title":"Cell Biochem Biophys"},{"key":"1844_CR319","volume":"100","author":"T Zhang","year":"2022","unstructured":"Zhang T et al (2022a) Saponins from Rhizoma Panacis Majoris induce autophagy and suppress inflammatory phenotype of RA fibroblast-like synoviocytes by inhibiting mTORC1. Phytomedicine 100:154081","journal-title":"Phytomedicine"},{"issue":"2","key":"1844_CR320","first-page":"786","volume":"36","author":"Y Zhang","year":"2022","unstructured":"Zhang Y et al (2022b) Pristimerin promotes autophagy and apoptosis by inhibiting Akt\/mTOR pathway in collagen-induced arthritis. Phytother Res 36(2):786\u2013798","journal-title":"Phytother Res"},{"issue":"5","key":"1844_CR321","first-page":"1501","volume":"38","author":"L Zhao","year":"2016","unstructured":"Zhao L et al (2016a) Astragaloside IV inhibits proliferation and promotes apoptosis in rheumatoid arthritis fibroblast-like synoviocytes. Int J Mol Med 38(5):1501\u20131508","journal-title":"Int J Mol Med"},{"issue":"7","key":"1844_CR322","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11655-014-1986-0","volume":"22","author":"Y Zhao","year":"2016","unstructured":"Zhao Y et al (2016b) Therapeutic effects of sinomenine combined with leflunomide in rheumatoid arthritis patients: a randomized controlled trial. Chin J Integr Med 22(7):485\u2013492","journal-title":"Chin J Integr Med"},{"issue":"6","key":"1844_CR323","first-page":"5041","volume":"15","author":"Y Zhao","year":"2018","unstructured":"Zhao Y et al (2018) Gambogic acid suppresses pro-inflammatory cytokine production by inhibiting MAPK and NF-\u03baB signaling pathways in macrophages. Exp Ther Med 15(6):5041\u20135046","journal-title":"Exp Ther Med"},{"key":"1844_CR324","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120426","volume":"599","author":"J Zhao","year":"2021","unstructured":"Zhao J et al (2021a) Intra-articular delivery of celastrol-loaded nanoparticles for rheumatoid arthritis treatment. Int J Pharm 599:120423","journal-title":"Int J Pharm"},{"key":"1844_CR325","volume":"12","author":"X Zhao","year":"2021","unstructured":"Zhao X et al (2021b) Pristimerin modulates Th17\/Treg balance via mTOR pathway inhibition in experimental autoimmune arthritis. Front Pharmacol 12:642823","journal-title":"Front Pharmacol"},{"key":"1844_CR326","volume":"13","author":"X Zhao","year":"2022","unstructured":"Zhao X et al (2022) Kaempferitrin modulates Th17\/Treg balance by targeting mTOR signaling in autoimmune inflammation. Front Pharmacol 13:891244","journal-title":"Front Pharmacol"},{"issue":"1","key":"1844_CR327","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1080\/10717544.2020.1760402","volume":"27","author":"X Zheng","year":"2020","unstructured":"Zheng X et al (2020) Development of lipid\u2013polymer hybrid nanoparticles for enhanced delivery of pristimerin: preparation, characterization and in vivo anti-inflammatory activity. Drug Deliv 27(1):1267\u20131278","journal-title":"Drug Deliv"},{"issue":"3","key":"1844_CR328","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.intimp.2013.09.015","volume":"17","author":"Y Zhou","year":"2013","unstructured":"Zhou Y et al (2013) Pristimerin suppresses inflammation and cartilage destruction in collagen-induced arthritis mice. Int Immunopharmacol 17(3):447\u2013453","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"1844_CR329","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/10717544.2021.2000679","volume":"28","author":"H Zhou","year":"2021","unstructured":"Zhou H et al (2021) Curcumin nanoparticles: Synthesis, bioavailability, pharmacokinetics and anti-inflammatory activity. Drug Deliv 28(1):497\u2013510","journal-title":"Drug Deliv"},{"key":"1844_CR330","volume":"108","author":"Y Zhou","year":"2022","unstructured":"Zhou Y et al (2022) Luteolin alleviates rheumatoid arthritis via AMPK\/mTOR-mediated autophagy activation in fibroblast-like synoviocytes. Int Immunopharmacol 108:108755","journal-title":"Int Immunopharmacol"},{"key":"1844_CR331","volume":"216","author":"J Zhou","year":"2023","unstructured":"Zhou J et al (2023) Targeted delivery of resveratrol using PLGA nanoparticles enhances intestinal absorption and bioavailability. Colloids Surf B Biointerfaces 216:112574","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1","key":"1844_CR332","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.1038\/ncomms5696","volume":"5","author":"L Zhu","year":"2014","unstructured":"Zhu L et al (2014) TSC1 controls macrophage polarization to prevent inflammatory disease. Nat Commun 5(1):4696","journal-title":"Nat Commun"},{"issue":"1\u20132","key":"1844_CR333","first-page":"20","volume":"504","author":"X Zhu","year":"2016","unstructured":"Zhu X et al (2016) Enhanced anti-tumor efficacy of gambogic acid encapsulated in mixed micelles for targeted delivery. Int J Pharm 504(1\u20132):20\u201328","journal-title":"Int J Pharm"},{"key":"1844_CR334","volume":"210","author":"Y Zhu","year":"2022","unstructured":"Zhu Y et al (2022) PEGylated liposomal pristimerin improves therapeutic efficacy in collagen-induced arthritis by enhancing bioavailability and reducing systemic toxicity. Colloids Surf B Biointerfaces 210:112224","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"5","key":"1844_CR335","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.cell.2011.02.014","volume":"144","author":"V Zinzalla","year":"2011","unstructured":"Zinzalla V et al (2011) Activation of mTORC2 by association with the ribosome. Cell 144(5):757\u2013768","journal-title":"Cell"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01844-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01844-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01844-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T19:12:47Z","timestamp":1757272367000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01844-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":334,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1844"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01844-5","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"assertion":[{"value":"7 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have consent to publish this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}